Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review

Lung cancer (LC) continues to pose the highest mortality and exhibits a common prevalence among all types of cancer. The genetic interaction between human eukaryotes and microbial cells plays a vital role in orchestrating every physiological activity of the host. The dynamic crosstalk between gut an...

Full description

Saved in:
Bibliographic Details
Published in:MedComm (2020) Vol. 5; no. 12; pp. e70018 - n/a
Main Authors: Thapa, Rajan, Magar, Anjana Thapa, Shrestha, Jesus, Panth, Nisha, Idrees, Sobia, Sadaf, Tayyaba, Bashyal, Saroj, Elwakil, Bassma H., Sugandhi, Vrashabh V., Rojekar, Satish, Nikhate, Ram, Gupta, Gaurav, Singh, Sachin Kumar, Dua, Kamal, Hansbro, Philip M, Paudel, Keshav Raj
Format: Journal Article
Language:English
Published: China John Wiley & Sons, Inc 01.12.2024
John Wiley and Sons Inc
Wiley
Subjects:
Chemotherapy
dysbiosis
gut microbiome
Immunotherapy
Lung cancer
Lung diseases
lung microbiome
probiotics
Radiation therapy
Review
lung cancer
gut microbiome
lung microbiome
dysbiosis
probiotics
ISSN:2688-2663, 2688-2663
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Lung cancer (LC) continues to pose the highest mortality and exhibits a common prevalence among all types of cancer. The genetic interaction between human eukaryotes and microbial cells plays a vital role in orchestrating every physiological activity of the host. The dynamic crosstalk between gut and lung microbiomes and the gut–lung axis communication network has been widely accepted as promising factors influencing LC progression. The advent of the 16s rDNA sequencing technique has opened new horizons for elucidating the lung microbiome and its potential pathophysiological role in LC and other infectious lung diseases using a molecular approach. Numerous studies have reported the direct involvement of the host microbiome in lung tumorigenesis processes and their impact on current treatment strategies such as radiotherapy, chemotherapy, or immunotherapy. The genetic and metabolomic cross‐interaction, microbiome‐dependent host immune modulation, and the close association between microbiota composition and treatment outcomes strongly suggest that designing microbiome‐based treatment strategies and investigating new molecules targeting the common holobiome could offer potential alternatives to develop effective therapeutic principles for LC treatment. This review aims to highlight the interaction between the host and microbiome in LC progression and the possibility of manipulating altered microbiome ecology as therapeutic targets. Host–microbiome interaction in lung cancer. Both local (lung) and distal (gut) microbiota play critical roles in lung cancer
AbstractList Lung cancer (LC) continues to pose the highest mortality and exhibits a common prevalence among all types of cancer. The genetic interaction between human eukaryotes and microbial cells plays a vital role in orchestrating every physiological activity of the host. The dynamic crosstalk between gut and lung microbiomes and the gut–lung axis communication network has been widely accepted as promising factors influencing LC progression. The advent of the 16s rDNA sequencing technique has opened new horizons for elucidating the lung microbiome and its potential pathophysiological role in LC and other infectious lung diseases using a molecular approach. Numerous studies have reported the direct involvement of the host microbiome in lung tumorigenesis processes and their impact on current treatment strategies such as radiotherapy, chemotherapy, or immunotherapy. The genetic and metabolomic cross‐interaction, microbiome‐dependent host immune modulation, and the close association between microbiota composition and treatment outcomes strongly suggest that designing microbiome‐based treatment strategies and investigating new molecules targeting the common holobiome could offer potential alternatives to develop effective therapeutic principles for LC treatment. This review aims to highlight the interaction between the host and microbiome in LC progression and the possibility of manipulating altered microbiome ecology as therapeutic targets. Host–microbiome interaction in lung cancer. Both local (lung) and distal (gut) microbiota play critical roles in lung cancer
Lung cancer (LC) continues to pose the highest mortality and exhibits a common prevalence among all types of cancer. The genetic interaction between human eukaryotes and microbial cells plays a vital role in orchestrating every physiological activity of the host. The dynamic crosstalk between gut and lung microbiomes and the gut–lung axis communication network has been widely accepted as promising factors influencing LC progression. The advent of the 16s rDNA sequencing technique has opened new horizons for elucidating the lung microbiome and its potential pathophysiological role in LC and other infectious lung diseases using a molecular approach. Numerous studies have reported the direct involvement of the host microbiome in lung tumorigenesis processes and their impact on current treatment strategies such as radiotherapy, chemotherapy, or immunotherapy. The genetic and metabolomic cross‐interaction, microbiome‐dependent host immune modulation, and the close association between microbiota composition and treatment outcomes strongly suggest that designing microbiome‐based treatment strategies and investigating new molecules targeting the common holobiome could offer potential alternatives to develop effective therapeutic principles for LC treatment. This review aims to highlight the interaction between the host and microbiome in LC progression and the possibility of manipulating altered microbiome ecology as therapeutic targets. Host–microbiome interaction in lung cancer. Both local (lung) and distal (gut) microbiota play critical roles in lung cancer
Abstract Lung cancer (LC) continues to pose the highest mortality and exhibits a common prevalence among all types of cancer. The genetic interaction between human eukaryotes and microbial cells plays a vital role in orchestrating every physiological activity of the host. The dynamic crosstalk between gut and lung microbiomes and the gut–lung axis communication network has been widely accepted as promising factors influencing LC progression. The advent of the 16s rDNA sequencing technique has opened new horizons for elucidating the lung microbiome and its potential pathophysiological role in LC and other infectious lung diseases using a molecular approach. Numerous studies have reported the direct involvement of the host microbiome in lung tumorigenesis processes and their impact on current treatment strategies such as radiotherapy, chemotherapy, or immunotherapy. The genetic and metabolomic cross‐interaction, microbiome‐dependent host immune modulation, and the close association between microbiota composition and treatment outcomes strongly suggest that designing microbiome‐based treatment strategies and investigating new molecules targeting the common holobiome could offer potential alternatives to develop effective therapeutic principles for LC treatment. This review aims to highlight the interaction between the host and microbiome in LC progression and the possibility of manipulating altered microbiome ecology as therapeutic targets.
Lung cancer (LC) continues to pose the highest mortality and exhibits a common prevalence among all types of cancer. The genetic interaction between human eukaryotes and microbial cells plays a vital role in orchestrating every physiological activity of the host. The dynamic crosstalk between gut and lung microbiomes and the gut–lung axis communication network has been widely accepted as promising factors influencing LC progression. The advent of the 16s rDNA sequencing technique has opened new horizons for elucidating the lung microbiome and its potential pathophysiological role in LC and other infectious lung diseases using a molecular approach. Numerous studies have reported the direct involvement of the host microbiome in lung tumorigenesis processes and their impact on current treatment strategies such as radiotherapy, chemotherapy, or immunotherapy. The genetic and metabolomic cross‐interaction, microbiome‐dependent host immune modulation, and the close association between microbiota composition and treatment outcomes strongly suggest that designing microbiome‐based treatment strategies and investigating new molecules targeting the common holobiome could offer potential alternatives to develop effective therapeutic principles for LC treatment. This review aims to highlight the interaction between the host and microbiome in LC progression and the possibility of manipulating altered microbiome ecology as therapeutic targets.
Lung cancer (LC) continues to pose the highest mortality and exhibits a common prevalence among all types of cancer. The genetic interaction between human eukaryotes and microbial cells plays a vital role in orchestrating every physiological activity of the host. The dynamic crosstalk between gut and lung microbiomes and the gut-lung axis communication network has been widely accepted as promising factors influencing LC progression. The advent of the 16s rDNA sequencing technique has opened new horizons for elucidating the lung microbiome and its potential pathophysiological role in LC and other infectious lung diseases using a molecular approach. Numerous studies have reported the direct involvement of the host microbiome in lung tumorigenesis processes and their impact on current treatment strategies such as radiotherapy, chemotherapy, or immunotherapy. The genetic and metabolomic cross-interaction, microbiome-dependent host immune modulation, and the close association between microbiota composition and treatment outcomes strongly suggest that designing microbiome-based treatment strategies and investigating new molecules targeting the common holobiome could offer potential alternatives to develop effective therapeutic principles for LC treatment. This review aims to highlight the interaction between the host and microbiome in LC progression and the possibility of manipulating altered microbiome ecology as therapeutic targets.Lung cancer (LC) continues to pose the highest mortality and exhibits a common prevalence among all types of cancer. The genetic interaction between human eukaryotes and microbial cells plays a vital role in orchestrating every physiological activity of the host. The dynamic crosstalk between gut and lung microbiomes and the gut-lung axis communication network has been widely accepted as promising factors influencing LC progression. The advent of the 16s rDNA sequencing technique has opened new horizons for elucidating the lung microbiome and its potential pathophysiological role in LC and other infectious lung diseases using a molecular approach. Numerous studies have reported the direct involvement of the host microbiome in lung tumorigenesis processes and their impact on current treatment strategies such as radiotherapy, chemotherapy, or immunotherapy. The genetic and metabolomic cross-interaction, microbiome-dependent host immune modulation, and the close association between microbiota composition and treatment outcomes strongly suggest that designing microbiome-based treatment strategies and investigating new molecules targeting the common holobiome could offer potential alternatives to develop effective therapeutic principles for LC treatment. This review aims to highlight the interaction between the host and microbiome in LC progression and the possibility of manipulating altered microbiome ecology as therapeutic targets.
Author Hansbro, Philip M
Idrees, Sobia
Bashyal, Saroj
Rojekar, Satish
Dua, Kamal
Singh, Sachin Kumar
Sugandhi, Vrashabh V.
Panth, Nisha
Thapa, Rajan
Gupta, Gaurav
Magar, Anjana Thapa
Nikhate, Ram
Elwakil, Bassma H.
Paudel, Keshav Raj
Sadaf, Tayyaba
Shrestha, Jesus
AuthorAffiliation 5 Department of Pharmacy, Manmohan Memorial Institute of Health Sciences Tribhuvan University, Soalteemode Kathmandu Nepal
9 Department of Pharmaceutics Dattakala Shikshan Sanstha, Dattakala college of pharmacy (Affiliated to Savitribai Phule Pune university Pune Maharashtra India
1 Department of Pharmacy, Universal college of medical sciences Tribhuvan University Bhairahawa Rupendehi Nepal
11 Centre of Medical and Bio‐allied Health Sciences Research Ajman University Ajman UAE
7 Department of pharmaceutical sciences, College of Pharmacy & Health Sciences St. John's University Queens New York USA
3 School of Biomedical Engineering University of Technology Sydney Sydney New South Wales Australia
14 Discipline of Pharmacy, Graduate School of Health University of Technology Sydney Ultimo New South Wales Australia
4 Centre for Inflammation, Faculty of Science, School of Life Sciences Centenary Institute and University of Technology Sydney Sydney New South Wales Australia
2 Department of Medicine Ka
AuthorAffiliation_xml – name: 3 School of Biomedical Engineering University of Technology Sydney Sydney New South Wales Australia
– name: 4 Centre for Inflammation, Faculty of Science, School of Life Sciences Centenary Institute and University of Technology Sydney Sydney New South Wales Australia
– name: 14 Discipline of Pharmacy, Graduate School of Health University of Technology Sydney Ultimo New South Wales Australia
– name: 1 Department of Pharmacy, Universal college of medical sciences Tribhuvan University Bhairahawa Rupendehi Nepal
– name: 5 Department of Pharmacy, Manmohan Memorial Institute of Health Sciences Tribhuvan University, Soalteemode Kathmandu Nepal
– name: 6 Department of Medical Laboratory Technology, Faculty of Applied Health Sciences Technology Pharos University in Alexandria Alexandria Egypt
– name: 11 Centre of Medical and Bio‐allied Health Sciences Research Ajman University Ajman UAE
– name: 10 Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences Saveetha University Chennai India
– name: 7 Department of pharmaceutical sciences, College of Pharmacy & Health Sciences St. John's University Queens New York USA
– name: 8 Department of Pharmacological Sciences Icahn School of Medicine at Mount Sinai New York New York USA
– name: 2 Department of Medicine Kathmandu Medical College Teaching Hospital, Sinamangal Kathmandu Nepal
– name: 13 Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine University of Technology Sydney Ultimo New South Wales Australia
– name: 9 Department of Pharmaceutics Dattakala Shikshan Sanstha, Dattakala college of pharmacy (Affiliated to Savitribai Phule Pune university Pune Maharashtra India
– name: 12 School of Pharmaceutical Sciences Lovely Professional University Phagwara India
Author_xml – sequence: 1
  givenname: Rajan
  surname: Thapa
  fullname: Thapa, Rajan
  organization: Tribhuvan University
– sequence: 2
  givenname: Anjana Thapa
  surname: Magar
  fullname: Magar, Anjana Thapa
  organization: Kathmandu Medical College Teaching Hospital, Sinamangal
– sequence: 3
  givenname: Jesus
  surname: Shrestha
  fullname: Shrestha, Jesus
  organization: University of Technology Sydney
– sequence: 4
  givenname: Nisha
  surname: Panth
  fullname: Panth, Nisha
  organization: Centenary Institute and University of Technology Sydney
– sequence: 5
  givenname: Sobia
  surname: Idrees
  fullname: Idrees, Sobia
  organization: Centenary Institute and University of Technology Sydney
– sequence: 6
  givenname: Tayyaba
  surname: Sadaf
  fullname: Sadaf, Tayyaba
  organization: Centenary Institute and University of Technology Sydney
– sequence: 7
  givenname: Saroj
  surname: Bashyal
  fullname: Bashyal, Saroj
  organization: Tribhuvan University, Soalteemode
– sequence: 8
  givenname: Bassma H.
  surname: Elwakil
  fullname: Elwakil, Bassma H.
  organization: Pharos University in Alexandria
– sequence: 9
  givenname: Vrashabh V.
  surname: Sugandhi
  fullname: Sugandhi, Vrashabh V.
  organization: St. John's University
– sequence: 10
  givenname: Satish
  surname: Rojekar
  fullname: Rojekar, Satish
  organization: Icahn School of Medicine at Mount Sinai
– sequence: 11
  givenname: Ram
  surname: Nikhate
  fullname: Nikhate, Ram
  organization: Dattakala Shikshan Sanstha, Dattakala college of pharmacy (Affiliated to Savitribai Phule Pune university
– sequence: 12
  givenname: Gaurav
  surname: Gupta
  fullname: Gupta, Gaurav
  organization: Ajman University
– sequence: 13
  givenname: Sachin Kumar
  surname: Singh
  fullname: Singh, Sachin Kumar
  organization: University of Technology Sydney
– sequence: 14
  givenname: Kamal
  surname: Dua
  fullname: Dua, Kamal
  organization: University of Technology Sydney
– sequence: 15
  givenname: Philip M
  surname: Hansbro
  fullname: Hansbro, Philip M
  email: Philip.hansbro@uts.edu.au
  organization: Centenary Institute and University of Technology Sydney
– sequence: 16
  givenname: Keshav Raj
  orcidid: 0000-0002-3591-2080
  surname: Paudel
  fullname: Paudel, Keshav Raj
  email: Keshavraj.paudel@uts.edu.au
  organization: Centenary Institute and University of Technology Sydney
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39584048$$D View this record in MEDLINE/PubMed
BookMark eNp9ksFu1DAQhiNUREvphQdAkbggpC22kzg2lwqtCqxU1AucLcceZ71K7MVOttqH4B14lj4ZzqZFbYU42Zr5_l-_x_MyO3LeQZa9xugcI0Q-9MqT8xohzJ5lJ4QytiCUFkcP7sfZWYwblOAK45qjF9lxwStWopKdZL9WznQjOAW5N3k7Drl0Ou9G1-Z6Hxvro425d3NFycSFfBt8GyBGm-oTPazBhrz3euzkcCjGielttEmUukFuYRysygcZWhjix1ze_la-3wZYg4t2B3mAnYWbV9lzI7sIZ3fnafbj8-X35dfF1fWX1fLT1UJVuGILbQrecM14aahBihvOWAOM0po0SBpTsJKqpuLKaAJSNZojI5mRimPKammK02w1-2ovN2IbbC_DXnhpxaHgQytkSIE7EFSr0lSgSsV5WReElYabQjdaS4oqrpPXxey1HZsetAI3BNk9Mn3ccXYtWr8TOD2FIk6Sw7s7h-B_jhAHkUanoOukAz9GUeCCUEzKekLfPkE3fgwuzSpRE4ApLxL15mGkv1nuvz0BaAZU8DEGMELZ4fB3KaHtBEZiWi4xLZc4LFeSvH8iuXf9J4xn-MZ2sP8PKb4tr8ms-QPH1OPZ
CitedBy_id crossref_primary_10_3389_fmicb_2025_1632435
crossref_primary_10_70749_ijbr_v2i02_291
crossref_primary_10_1007_s00204_025_04136_7
crossref_primary_10_3389_fimmu_2025_1595977
crossref_primary_10_3390_microorganisms13030514
crossref_primary_10_3389_fimmu_2025_1589843
crossref_primary_10_1002_mog2_70023
crossref_primary_10_1016_j_arr_2025_102775
crossref_primary_10_1016_j_dsx_2025_103208
crossref_primary_10_1016_j_nano_2025_102855
crossref_primary_10_1186_s12645_025_00310_9
crossref_primary_10_3389_fcimb_2025_1565887
crossref_primary_10_3389_fmicb_2025_1645577
crossref_primary_10_3389_fphar_2025_1551411
Cites_doi 10.4155/fmc-2019-0338
10.1111/resp.12985
10.1056/NEJMoa040938
10.12703/P6-97
10.1038/nri2316
10.1038/s41571-023-00798-3
10.1016/j.bbih.2023.100671
10.1016/j.jtho.2019.04.007
10.1186/s13059-016-1021-1
10.3390/microorganisms8111741
10.1002/cncr.31196
10.1371/journal.pone.0126312
10.1016/j.cell.2016.01.049
10.1146/annurev.immunol.21.120601.141135
10.3389/fmicb.2022.999001
10.1056/NEJMoa1916623
10.3389/fcimb.2021.665159
10.1016/S2213-2600(18)30510-1
10.1002/ijc.22262
10.3389/fcimb.2019.00090
10.2174/1568005014606017
10.1016/j.trsl.2012.02.005
10.1152/ajpgi.00206.2004
10.1016/S2666-5247(22)00203-8
10.3389/fmed.2020.00554
10.3389/fimmu.2019.00360
10.1128/mBio.00037-15
10.1016/j.jaci.2016.10.050
10.1002/anie.201710398
10.3322/caac.21820
10.1158/1078-0432.CCR-19-0960
10.1016/j.lungcan.2016.10.016
10.18632/oncotarget.186
10.1016/j.jconrel.2021.08.010
10.1016/j.ymben.2015.03.007
10.1016/j.immuni.2018.04.022
10.3389/fimmu.2018.00374
10.1016/j.lungcan.2019.08.022
10.1016/j.ijpharm.2022.121790
10.1016/j.ijbiomac.2022.07.156
10.1038/s41586-019-1238-8
10.1016/j.rvsc.2021.03.006
10.3389/fmicb.2018.01757
10.3390/antiox11010065
10.1038/s41392-023-01722-y
10.1371/journal.pcbi.1002808
10.1002/ijc.33557
10.1186/s12931-019-1246-0
10.1038/s41467-022-35580-z
10.1038/s41579-020-0438-4
10.1371/journal.pone.0066019
10.1586/eri.11.141
10.1164/rccm.201104-0655OC
10.1136/gutjnl-2017-313789
10.1158/0008-5472.CAN-16-2929
10.1016/j.isci.2022.105923
10.1111/resp.12990
10.2217/imt-2018-0144
10.1038/nature12477
10.1038/nm.3568
10.1111/jfbc.13572
10.1038/s41564-019-0574-7
10.21037/tlcr-20-156
10.1016/j.cbi.2023.110737
10.1080/03602532.2020.1714645
10.21037/apm-20-2183
10.1177/20503121211034366
10.1038/nm.2224
10.1038/s43018-022-00351-8
10.1111/jcmm.14289
10.1126/scitranslmed.3000251
10.1007/s11356-022-19158-2
10.1007/978-981-99-7141-1
10.4046/trd.2018.0068
10.1016/j.jtcvs.2020.01.104
10.1089/rej.2022.0039
10.1155/2020/2969287
10.1128/IAI.00522-09
10.1002/cncr.22315
10.1002/em.21878
10.1016/j.intimp.2020.107272
10.1183/13993003.01406-2015
10.1186/s40168-016-0225-7
10.1016/S2214-109X(19)30488-7
10.1002/ijc.24636
10.21037/jtd-22-1825
10.1016/j.ajpath.2017.01.003
10.1146/annurev.physiol.66.032102.135749
10.1016/j.jtcvs.2018.08.075
10.1186/s13062-023-00357-x
10.1146/annurev-immunol-051116-052133
10.1155/2018/6916797
10.1016/j.cell.2013.12.016
10.1186/s40168-020-00811-2
10.1111/1759-7714.15177
10.1371/journal.ppat.1006798
10.3389/fmicb.2023.1121863
10.1002/pro6.1096
10.3389/fmicb.2023.1165360
10.1007/s13238-020-00813-8
10.1016/j.biopha.2022.113528
10.3389/fgene.2023.1120815
10.3389/fmicb.2015.01050
10.1053/j.gastro.2017.09.006
10.1016/S0360-3016(00)01401-2
10.3389/fcimb.2021.625913
10.1016/j.bpg.2017.10.006
10.1017/S0007114512005235
10.1016/j.jddst.2023.104328
10.1186/s12943-019-1008-0
10.1186/s13014-020-01735-9
10.1172/JCI16889
10.1186/s40168-020-00845-6
10.3389/fimmu.2020.00645
10.1126/science.abc4552
10.1172/JCI155101
10.1016/j.carbpol.2020.115957
10.2741/4847
10.1111/jnc.12718
10.1142/S0192415X22500951
10.3389/fphys.2018.01168
10.7812/TPP/19.129
10.1371/journal.pone.0016384
10.3389/fcimb.2020.00009
10.1016/j.pt.2020.04.010
10.1111/1469-0691.12023
10.1172/JCI44871
10.1038/cgt.2011.57
10.1016/j.clim.2022.109013
10.1038/s41590-019-0451-9
10.1038/nrmicro2974
10.1038/nmicrobiol.2016.31
10.1016/j.immuni.2016.09.009
10.3390/pharmaceutics13122008
10.1126/science.1223813
10.1080/19490976.2019.1709387
10.3389/fgene.2020.566244
10.1007/s00018-020-03452-8
10.1016/j.semcancer.2021.07.005
10.7554/eLife.04186
10.1038/s41564-019-0498-2
10.1038/nrmicro.2016.142
10.3390/dna3010002
10.1111/cmi.12308
10.3389/fmicb.2017.01732
10.1245/s10434-020-08241-y
10.1186/s13054-020-03320-8
10.1038/nm.3854
10.1038/s41467-018-03150-x
10.1186/s13059-020-01961-0
10.1016/S0140-6736(14)61136-3
10.1016/j.anaerobe.2015.01.004
10.1186/s12943-023-01740-y
10.1177/0884533615609899
10.1093/annonc/mdw321
10.1164/rccm.201710-2118OC
10.1016/j.critrevonc.2021.103404
10.3390/cancers13092124
10.1097/SHK.0000000000000565
10.1111/1759-7714.13711
10.1016/S1470-2045(12)70137-7
10.1053/j.gastro.2013.04.056
10.1038/s41419-018-1237-y
10.1126/science.aac4255
10.1152/jappl.1987.63.5.2075
10.1073/pnas.0504830102
10.1016/j.oraloncology.2006.02.009
10.1186/s12931-018-0959-9
10.1016/j.ejphar.2021.174581
10.1038/s41574-020-00427-4
10.1016/j.clnu.2016.09.025
10.1038/s41598-019-49195-w
10.3389/fonc.2022.1063100
10.1007/s12672-023-00748-6
10.3389/fmicb.2021.779620
10.1038/s41385-019-0144-6
10.1186/s12967-019-1971-7
10.1371/journal.pone.0177062
10.1016/j.lungcan.2018.07.013
10.3390/nu13113866
10.1186/s13059-018-1501-6
10.1002/ijc.31098
10.1007/s12032-023-01954-6
10.3390/ijms25074051
10.1016/j.critrevonc.2013.06.011
10.1038/s42003-023-04592-w
10.1158/0008-5472.CAN-18-4108
10.1126/science.aan3706
10.1016/j.celrep.2018.08.090
10.1016/j.immuni.2017.04.005
10.1159/000446447
10.3390/cancers13010013
10.3389/fphar.2021.643283
10.1007/s00018-018-2943-4
10.1038/nm.4517
10.1164/rccm.201210-1913OC
10.3892/mmr.2023.13082
10.1007/s00432-010-0934-4
10.1016/j.crvi.2018.03.004
10.1093/jnci/djv199
10.1007/s00203-024-03834-7
10.1183/09031936.01.00228801
10.3389/fimmu.2024.1343450
10.1159/000342079
10.1126/science.aay9189
10.1016/j.jep.2023.116629
10.1038/s41419-023-05560-2
10.1016/j.cell.2012.04.037
10.1016/j.biopha.2019.109363
10.3389/fonc.2021.720842
10.1158/1055-9965.EPI-10-1166
10.1007/s00394-017-1445-8
10.1902/jop.2016.150597
10.1016/j.adro.2020.10.018
10.3389/fmicb.2018.01835
10.1016/j.dci.2006.06.003
10.1164/rccm.201210-1937OC
10.3389/fimmu.2023.1171649
10.1038/nrc.2016.66
10.1016/j.carbpol.2017.12.009
10.1016/j.crfs.2022.08.010
10.2174/138920112800784835
10.1038/ncomms7734
10.1136/gutjnl-2017-315537
10.1126/scitranslmed.aau9959
10.3390/molecules28083475
10.1111/1759-7714.13442
10.1038/s41591-022-01779-2
10.3389/fimmu.2020.00357
10.4238/2015.May.25.16
10.1186/s12887-019-1782-2
10.1189/jlb.3MR0316-106R
10.1016/j.cell.2014.09.053
10.1126/science.1240527
10.3389/fimmu.2021.772532
10.1016/S0140-6736(03)12489-0
10.3390/cancers14215405
10.1038/s41392-023-01406-7
10.14316/pmp.2020.31.3.124
10.1016/j.jddst.2023.104579
10.1183/09031936.00062212
10.3389/fonc.2020.576855
10.1038/nrc3239
10.1007/s10517-011-1457-y
10.1186/s12865-016-0187-3
10.1016/j.bbagrm.2019.04.006
10.1016/j.ijbiomac.2022.09.271
10.1111/crj.12094
10.1016/j.cmet.2012.10.007
10.1016/j.trecan.2020.12.010
10.1016/j.chembiol.2015.08.005
10.1038/s41392-022-00974-4
10.1097/00005176-199901000-00007
10.1136/gutjnl-2023-330521
10.1186/s13568-022-01428-4
10.1111/j.1365-2672.2007.03322.x
10.1155/2014/462740
10.7150/ijbs.35980
10.1183/16000617.0299-2020
10.3748/wjg.v16.i28.3529
10.1038/sj.onc.1207515
10.1158/1055-9965.EPI-07-2817
10.1016/j.cbi.2022.110282
10.1046/j.1365-2567.2002.01498.x
10.1101/gr.122705.111
10.1016/B978-0-12-820658-4.00023-6
10.1002/anie.200901917
10.1038/mi.2016.108
10.1002/cam4.5312
10.1038/nrc.2016.36
10.1016/j.bbcan.2022.188846
10.1002/cncr.35128
10.1016/j.ijmm.2009.08.006
10.1016/j.ctrv.2020.101978
10.1002/jobm.202000575
10.1126/science.1127059
10.1016/j.ejmech.2016.01.012
10.1371/journal.pone.0017479
10.1016/j.fshw.2017.07.003
10.1007/978-981-15-2385-4_5
10.1177/1099800420942830
10.21037/jtd-20-2137
10.1038/s41392-021-00687-0
10.1016/j.celrep.2016.05.047
10.1158/1541-7786.MCR-18-0357
10.3390/nu11102403
10.1002/cam4.2564
10.1016/j.freeradbiomed.2016.11.013
10.3390/molecules27185838
10.3748/wjg.v23.i12.2149
10.1073/pnas.0500098102
10.3889/oamjms.2017.122
10.1158/2326-6066.CIR-20-0051
10.1016/j.ijbiomac.2022.05.185
10.1016/j.addr.2020.05.002
10.1093/annonc/mdy103
10.1080/21507740.2021.1958096
10.1136/gutjnl-2020-321031
10.1016/S1875-5364(19)30003-2
10.1038/nature09199
10.1183/16000617.00002315
10.1016/j.cllc.2023.06.011
10.4049/jimmunol.176.4.2161
10.1016/j.heliyon.2024.e24032
10.1016/j.lfs.2020.118463
10.1002/ame2.12022
10.4049/jimmunol.178.4.2000
10.1038/s41385-019-0160-6
10.1186/s40168-018-0446-z
10.1016/j.biopha.2022.112951
10.1038/s41419-018-0304-8
10.1016/j.critrevonc.2019.06.004
10.1186/1749-8090-6-137
10.1038/ni1112
10.1016/j.lfs.2021.119436
10.1002/mnfr.202100096
10.1093/nutrit/nux062
10.1038/nrd1902
10.3390/ijms241411855
10.1186/s10020-024-00873-0
10.1200/JCO.2009.27.6204
10.1016/j.intimp.2023.109708
10.1038/s41591-021-01450-2
10.1371/journal.ppat.1004923
10.1002/cam4.4994
10.1155/2017/5035371
10.1164/rccm.201508-1545CI
10.1007/978-1-4684-5766-7_52
10.1016/j.trecan.2019.12.007
10.1099/jmm.0.04845-0
10.1038/s42255-023-00898-5
10.1016/j.nano.2020.102303
10.3389/fonc.2021.750657
10.1073/pnas.1006451107
10.1002/cpt.810
10.1186/s12935-023-02990-y
10.3389/fmicb.2020.00301
10.3389/fonc.2018.00520
ContentType Journal Article
Copyright 2024 The Author(s). published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2024 The Author(s). published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
– notice: 2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
– notice: 2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
K9.
7X8
5PM
DOA
DOI 10.1002/mco2.70018
DatabaseName Wiley-Blackwell Open Access Titles
CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList


ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate THAPA et al
EISSN 2688-2663
EndPage n/a
ExternalDocumentID oai_doaj_org_article_6dc4f5ec4c99473284f9f3dbdda6059d
PMC11586092
39584048
10_1002_mco2_70018
MCO270018
Genre reviewArticle
Journal Article
Review
GrantInformation_xml – fundername: International Association for the Study of Lung Cancer
– fundername: Prevent Cancer Foundation
GroupedDBID 0R~
1OC
24P
53G
7X7
8FI
8FJ
AAHHS
ABUWG
ACCFJ
ACCMX
ADPDF
AEEZP
AEQDE
AFKRA
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
BENPR
CCPQU
EBS
FYUFA
GROUPED_DOAJ
HMCUK
IAO
IHR
INH
ITC
M~E
OK1
OVD
RPM
TEORI
UKHRP
WIN
AAMMB
AAYXX
AEFGJ
AGXDD
AIDQK
AIDYY
ALUQN
CITATION
PHGZM
NPM
K9.
7X8
5PM
ID FETCH-LOGICAL-c5158-df39b9d894f6f0c9f988be86672b0aff3846cb59cfd2eacbd90fa8fac91687af3
IEDL.DBID 24P
ISICitedReferencesCount 16
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001369991100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2688-2663
IngestDate Fri Oct 03 12:50:37 EDT 2025
Tue Nov 04 02:04:51 EST 2025
Sat Sep 27 20:14:56 EDT 2025
Tue Oct 07 06:58:31 EDT 2025
Mon Jul 21 05:55:33 EDT 2025
Sat Nov 29 08:11:52 EST 2025
Tue Nov 18 19:47:20 EST 2025
Wed Jan 22 17:13:58 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords lung cancer
gut microbiome
lung microbiome
dysbiosis
probiotics
Language English
License Attribution
http://creativecommons.org/licenses/by/4.0
2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5158-df39b9d894f6f0c9f988be86672b0aff3846cb59cfd2eacbd90fa8fac91687af3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-3591-2080
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmco2.70018
PMID 39584048
PQID 3147231693
PQPubID 5014760
PageCount 30
ParticipantIDs doaj_primary_oai_doaj_org_article_6dc4f5ec4c99473284f9f3dbdda6059d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11586092
proquest_miscellaneous_3132612472
proquest_journals_3147231693
pubmed_primary_39584048
crossref_citationtrail_10_1002_mco2_70018
crossref_primary_10_1002_mco2_70018
wiley_primary_10_1002_mco2_70018_MCO270018
PublicationCentury 2000
PublicationDate December 2024
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: December 2024
PublicationDecade 2020
PublicationPlace China
PublicationPlace_xml – name: China
– name: Beijing
– name: Hoboken
PublicationTitle MedComm (2020)
PublicationTitleAlternate MedComm (2020)
PublicationYear 2024
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2021; 65
2019; 11
2019; 10
2019; 12
2004; 23
2019; 15
2019; 14
2019; 17
2020; 16
2019; 19
2024; 30
2019; 18
2004; 5
2012; 18
2020; 13
2020; 12
2001; 49
2020; 11
2012; 16
2020; 10
2012; 13
2012; 12
2017; 75
2007; 178
2010; 1
2019; 20
2017; 77
2019; 23
2019; 25
2016; 43
2019; 157
2024; 25
2010; 2
2016; 47
2016; 46
2011; 121
2016; 45
2023; 1878
2011; 137
2018; 341
2006; 119
2021; 45
2020; 383
2013; 88
2013; 109
2020; 261
1999; 28
2013; 342
2020; 36
2024; 10
2022; 86
2016; 17
2024; 15
2016; 16
2011; 6
2016; 15
2017; 139
2011; 9
2015; 350
2009; 77
2016; 1
1987; 63
2022; 3
2018; 359
2020; 31
2022; 5
2022; 7
2020; 27
2005; 4
2016; 20
2023; 313
2020; 25
2020; 24
2020; 21
2021; 61
2006; 107
2016; 27
2022; 621
2016; 25
2004; 66
2023; 32
2016; 109
2017; 46
1991; 51
2016; 102
2020; 368
2024; 73
2016; 100
2024; 74
2008; 8
2007; 31
2023; 20
2020; 8
2020; 7
2021; 912
2017; 31
2020; 6
2023; 24
2020; 4
2023; 22
2014; 3
2023; 23
2023; 28
2013; 11
2020; 52
2017; 36
2023; 26
2017; 35
2020; 9
2002; 107
2001; 18
2014; 8
2012; 336
2014; 6
2014; 55
2021; 9
2021; 7
2021; 6
2015; 6
2023; 14
2015; 5
2019; 70
2015; 4
2023; 12
2017; 2017
2020; 85
2023; 18
2023; 15
2019; 76
2019; 79
2017; 22
2013; 42
2017; 23
2020; 77
2018; 67
2021; 91
2018; 2018
2019; 82
2011; 108
2023
2017; 15
2022
2005; 288
2020
2021; 337
1946; 6
2017; 10
2017; 12
2017; 18
2020; 235
2007; 43
2017; 102
2017; 105
2018; 57
2007; 102
2010; 16
2021; 168
2010; 466
2022; 25
2006; 176
2021; 161
2021; 164
2024
2019; 569
2022; 218
2013; 8
2014; 130
2003; 52
2023; 82
2022; 27
2018; 48
2022; 28
2022; 29
2014; 20
2022; 213
2018; 6
2018; 9
2018; 8
1990
2018; 1
2005; 102
2010; 28
2024; 9
2006; 26
2014; 16
2021; 276
2009; 125
2019; 7
2018; 29
2019; 9
2019; 4
2018; 183
2013; 500
2021; 149
2014; 2014
2013; 187
2022; 238
2018; 21
2016; 164
2014; 159
2014; 156
2018; 24
2019; 1862
2022; 222
2018; 19
2023; 40
2018; 198
2020; 2020
2021; 136
2022; 12
2024; 130
2022; 13
2021; 371
2022; 14
2022; 11
2018; 10
2014; 384
2003; 21
2018; 14
2017; 5
2012; 61
2017; 6
2021; 27
2022; 132
2017; 8
2021; 23
2023; 5
2022; 71
2023; 6
2018; 124
2023; 8
2015; 30
2015; 33
2012; 160
2010; 300
2023; 3
2015; 107
2011; 152
2021; 30
2011; 18
2003; 111
2009; 48
2021; 31
2016; 87
2011; 20
2011; 21
2019; 118
2016; 193
2003; 361
2018; 142
2022; 153
2015; 14
2022; 150
2022; 50
2024; 206
2015; 11
2008; 17
2015; 10
2013; 145
2023; 369
2006; 313
2019; 141
2012; 149
2020; 1238
2021; 13
2021; 16
2018; 154
2021; 12
2021; 11
2015; 29
2004; 350
2015; 22
2015; 21
2021; 19
2023; 115
2019; 136
2001; 1
2017; 187
2011; 184
2012; 8
1994; 54
e_1_2_12_130_1
e_1_2_12_191_1
e_1_2_12_2_1
e_1_2_12_138_1
e_1_2_12_319_1
e_1_2_12_115_1
e_1_2_12_153_1
e_1_2_12_199_1
e_1_2_12_345_1
e_1_2_12_85_1
e_1_2_12_322_1
e_1_2_12_262_1
e_1_2_12_24_1
e_1_2_12_47_1
Huang D (e_1_2_12_176_1) 2019; 9
e_1_2_12_201_1
e_1_2_12_224_1
e_1_2_12_247_1
e_1_2_12_285_1
e_1_2_12_62_1
e_1_2_12_180_1
e_1_2_12_209_1
Organization WH (e_1_2_12_32_1)
e_1_2_12_104_1
e_1_2_12_127_1
e_1_2_12_142_1
e_1_2_12_165_1
e_1_2_12_188_1
e_1_2_12_307_1
e_1_2_12_333_1
e_1_2_12_356_1
e_1_2_12_96_1
e_1_2_12_273_1
e_1_2_12_139_1
e_1_2_12_310_1
e_1_2_12_35_1
e_1_2_12_250_1
e_1_2_12_58_1
e_1_2_12_12_1
e_1_2_12_73_1
e_1_2_12_212_1
e_1_2_12_258_1
e_1_2_12_296_1
e_1_2_12_50_1
e_1_2_12_3_1
e_1_2_12_152_1
e_1_2_12_190_1
e_1_2_12_137_1
e_1_2_12_114_1
e_1_2_12_175_1
e_1_2_12_198_1
e_1_2_12_346_1
e_1_2_12_63_1
e_1_2_12_323_1
e_1_2_12_300_1
e_1_2_12_240_1
e_1_2_12_25_1
e_1_2_12_48_1
e_1_2_12_263_1
e_1_2_12_202_1
e_1_2_12_286_1
e_1_2_12_40_1
e_1_2_12_225_1
Kim K (e_1_2_12_248_1) 2019; 20
e_1_2_12_149_1
e_1_2_12_308_1
e_1_2_12_126_1
e_1_2_12_164_1
e_1_2_12_334_1
Zhang WQ (e_1_2_12_141_1) 2018; 10
e_1_2_12_103_1
e_1_2_12_187_1
e_1_2_12_357_1
e_1_2_12_74_1
e_1_2_12_97_1
e_1_2_12_311_1
e_1_2_12_251_1
e_1_2_12_36_1
e_1_2_12_59_1
e_1_2_12_13_1
e_1_2_12_213_1
e_1_2_12_259_1
e_1_2_12_274_1
e_1_2_12_297_1
e_1_2_12_51_1
e_1_2_12_193_1
e_1_2_12_238_1
e_1_2_12_19_1
e_1_2_12_170_1
e_1_2_12_132_1
e_1_2_12_178_1
e_1_2_12_324_1
e_1_2_12_155_1
e_1_2_12_347_1
e_1_2_12_106_1
e_1_2_12_129_1
e_1_2_12_301_1
e_1_2_12_22_1
e_1_2_12_45_1
e_1_2_12_68_1
e_1_2_12_241_1
e_1_2_12_264_1
e_1_2_12_83_1
e_1_2_12_203_1
e_1_2_12_226_1
e_1_2_12_287_1
e_1_2_12_60_1
e_1_2_12_182_1
e_1_2_12_249_1
e_1_2_12_350_1
e_1_2_12_121_1
e_1_2_12_309_1
e_1_2_12_144_1
e_1_2_12_167_1
e_1_2_12_335_1
e_1_2_12_358_1
e_1_2_12_118_1
e_1_2_12_312_1
e_1_2_12_33_1
e_1_2_12_56_1
e_1_2_12_79_1
e_1_2_12_290_1
e_1_2_12_252_1
e_1_2_12_8_1
e_1_2_12_10_1
e_1_2_12_94_1
e_1_2_12_237_1
e_1_2_12_275_1
e_1_2_12_71_1
Qiao D (e_1_2_12_196_1) 2015; 5
e_1_2_12_214_1
e_1_2_12_298_1
e_1_2_12_216_1
e_1_2_12_239_1
e_1_2_12_192_1
e_1_2_12_340_1
Nauts HC (e_1_2_12_229_1) 1946; 6
e_1_2_12_116_1
e_1_2_12_131_1
e_1_2_12_154_1
e_1_2_12_177_1
e_1_2_12_325_1
e_1_2_12_337_1
e_1_2_12_302_1
e_1_2_12_128_1
e_1_2_12_23_1
e_1_2_12_46_1
e_1_2_12_69_1
Kawato Y (e_1_2_12_235_1) 1991; 51
e_1_2_12_280_1
e_1_2_12_265_1
e_1_2_12_242_1
e_1_2_12_61_1
e_1_2_12_84_1
e_1_2_12_204_1
e_1_2_12_288_1
e_1_2_12_227_1
e_1_2_12_181_1
e_1_2_12_351_1
e_1_2_12_120_1
e_1_2_12_105_1
e_1_2_12_143_1
e_1_2_12_189_1
e_1_2_12_166_1
e_1_2_12_336_1
e_1_2_12_348_1
Ramesh V (e_1_2_12_136_1) 2023
e_1_2_12_313_1
e_1_2_12_117_1
e_1_2_12_34_1
e_1_2_12_57_1
Riaz A (e_1_2_12_338_1) 2019; 70
e_1_2_12_291_1
e_1_2_12_230_1
e_1_2_12_253_1
e_1_2_12_11_1
e_1_2_12_72_1
e_1_2_12_95_1
e_1_2_12_215_1
e_1_2_12_276_1
e_1_2_12_299_1
e_1_2_12_9_1
e_1_2_12_217_1
e_1_2_12_195_1
e_1_2_12_6_1
e_1_2_12_172_1
e_1_2_12_17_1
e_1_2_12_111_1
e_1_2_12_157_1
e_1_2_12_341_1
e_1_2_12_134_1
e_1_2_12_315_1
e_1_2_12_108_1
e_1_2_12_281_1
e_1_2_12_303_1
e_1_2_12_20_1
e_1_2_12_66_1
e_1_2_12_43_1
e_1_2_12_89_1
e_1_2_12_220_1
e_1_2_12_243_1
e_1_2_12_266_1
e_1_2_12_289_1
e_1_2_12_81_1
e_1_2_12_161_1
e_1_2_12_184_1
e_1_2_12_205_1
GonzAlez I (e_1_2_12_211_1) 2018; 21
e_1_2_12_100_1
e_1_2_12_123_1
e_1_2_12_146_1
e_1_2_12_169_1
e_1_2_12_352_1
e_1_2_12_28_1
Bibbo S (e_1_2_12_86_1) 2016; 20
e_1_2_12_314_1
e_1_2_12_326_1
e_1_2_12_31_1
e_1_2_12_77_1
e_1_2_12_292_1
e_1_2_12_349_1
e_1_2_12_54_1
e_1_2_12_254_1
e_1_2_12_231_1
e_1_2_12_92_1
e_1_2_12_277_1
e_1_2_12_171_1
e_1_2_12_194_1
e_1_2_12_218_1
e_1_2_12_18_1
e_1_2_12_110_1
e_1_2_12_342_1
e_1_2_12_133_1
e_1_2_12_156_1
e_1_2_12_316_1
e_1_2_12_282_1
e_1_2_12_21_1
e_1_2_12_44_1
e_1_2_12_339_1
e_1_2_12_107_1
McCarthy EF (e_1_2_12_228_1) 2006; 26
Mitsudomi T (e_1_2_12_67_1) 2014; 3
e_1_2_12_244_1
e_1_2_12_221_1
e_1_2_12_82_1
e_1_2_12_267_1
e_1_2_12_206_1
e_1_2_12_160_1
e_1_2_12_183_1
e_1_2_12_122_1
e_1_2_12_168_1
e_1_2_12_330_1
e_1_2_12_29_1
e_1_2_12_353_1
Ali S (e_1_2_12_75_1) 2022
e_1_2_12_145_1
e_1_2_12_304_1
e_1_2_12_270_1
e_1_2_12_293_1
e_1_2_12_119_1
e_1_2_12_327_1
e_1_2_12_55_1
e_1_2_12_78_1
e_1_2_12_232_1
e_1_2_12_255_1
e_1_2_12_278_1
e_1_2_12_7_1
e_1_2_12_70_1
e_1_2_12_93_1
e_1_2_12_4_1
e_1_2_12_174_1
e_1_2_12_219_1
e_1_2_12_151_1
e_1_2_12_38_1
e_1_2_12_159_1
e_1_2_12_343_1
e_1_2_12_317_1
e_1_2_12_113_1
e_1_2_12_197_1
e_1_2_12_41_1
e_1_2_12_87_1
Gupta E (e_1_2_12_236_1) 1994; 54
e_1_2_12_283_1
e_1_2_12_64_1
e_1_2_12_320_1
e_1_2_12_260_1
e_1_2_12_26_1
e_1_2_12_222_1
e_1_2_12_245_1
e_1_2_12_268_1
e_1_2_12_140_1
e_1_2_12_163_1
e_1_2_12_207_1
e_1_2_12_49_1
e_1_2_12_148_1
e_1_2_12_331_1
e_1_2_12_354_1
e_1_2_12_102_1
e_1_2_12_125_1
e_1_2_12_186_1
e_1_2_12_305_1
e_1_2_12_52_1
e_1_2_12_98_1
e_1_2_12_271_1
e_1_2_12_328_1
e_1_2_12_294_1
e_1_2_12_37_1
e_1_2_12_14_1
e_1_2_12_90_1
e_1_2_12_233_1
e_1_2_12_279_1
e_1_2_12_210_1
e_1_2_12_256_1
e_1_2_12_150_1
e_1_2_12_173_1
Yan X (e_1_2_12_179_1) 2015; 5
e_1_2_12_5_1
e_1_2_12_16_1
e_1_2_12_112_1
e_1_2_12_135_1
e_1_2_12_158_1
e_1_2_12_39_1
e_1_2_12_318_1
e_1_2_12_344_1
e_1_2_12_42_1
e_1_2_12_65_1
e_1_2_12_88_1
e_1_2_12_109_1
e_1_2_12_284_1
e_1_2_12_321_1
e_1_2_12_261_1
e_1_2_12_80_1
e_1_2_12_200_1
e_1_2_12_223_1
e_1_2_12_269_1
e_1_2_12_246_1
e_1_2_12_185_1
e_1_2_12_208_1
e_1_2_12_162_1
e_1_2_12_27_1
e_1_2_12_101_1
e_1_2_12_147_1
e_1_2_12_332_1
e_1_2_12_306_1
e_1_2_12_355_1
e_1_2_12_124_1
e_1_2_12_30_1
e_1_2_12_53_1
e_1_2_12_76_1
e_1_2_12_99_1
e_1_2_12_272_1
e_1_2_12_295_1
e_1_2_12_329_1
e_1_2_12_15_1
e_1_2_12_91_1
e_1_2_12_234_1
e_1_2_12_257_1
References_xml – volume: 6
  start-page: 221
  issue: 1
  year: 2023
  article-title: Interpersonal variability of the human gut virome confounds disease signal detection in IBD
  publication-title: Commun Biol
– volume: 336
  start-page: 1262
  issue: 6086
  year: 2012
  end-page: 1267
  article-title: Host‐gut microbiota metabolic interactions
  publication-title: Science
– volume: 2020
  year: 2020
  article-title: Akkermansia muciniphila enhances the antitumor effect of cisplatin in lewis lung cancer mice
  publication-title: J Immunol Res
– volume: 8
  start-page: 520
  year: 2018
  article-title: Dysbiosis of the salivary microbiome is associated with non‐smoking female lung cancer and correlated with immunocytochemistry markers
  publication-title: Front Oncol
– volume: 159
  start-page: 789
  issue: 4
  year: 2014
  end-page: 799
  article-title: Human genetics shape the gut microbiome
  publication-title: Cell
– volume: 119
  start-page: 2840
  issue: 12
  year: 2006
  end-page: 2850
  article-title: Differential expression and activation of NF‐kappaB family proteins during oral carcinogenesis: role of high risk human papillomavirus infection
  publication-title: Int J Cancer
– volume: 13
  start-page: 3866
  issue: 11
  year: 2021
  article-title: Microbiota in health and disease‐potential clinical applications
  publication-title: Nutrients
– volume: 30
  issue: 160
  year: 2021
  article-title: The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health
  publication-title: Eur Respir Rev
– volume: 20
  start-page: 1279
  issue: 10
  year: 2019
  end-page: 1290
  article-title: The influence of the microbiome on respiratory health
  publication-title: Nat Immunol
– volume: 28
  start-page: 3475
  issue: 8
  year: 2023
  article-title: Exploring the remarkable chemotherapeutic potential of polyphenolic antioxidants in battling various forms of cancer
  publication-title: Molecules
– volume: 7
  start-page: 554
  year: 2020
  article-title: Role of lung microbiome in innate immune response associated with chronic lung diseases
  publication-title: Front Med (Lausanne)
– volume: 9
  start-page: 4211
  issue: 6
  year: 2020
  end-page: 4227
  article-title: The gut microbiome can be used to predict the gastrointestinal response and efficacy of lung cancer patients undergoing chemotherapy
  publication-title: Ann Palliat Med
– volume: 24
  start-page: 613
  issue: 7
  year: 2023
  end-page: 620
  article-title: Infectious complications in patients with non‐small cell lung cancer treated with immune checkpoint inhibitors
  publication-title: Clin Lung Cancer
– volume: 57
  start-page: 2307
  issue: 9
  year: 2018
  end-page: 2313
  article-title: Lessons to be learned: the molecular basis of kinase‐targeted therapies and drug resistance in non‐small cell lung cancer
  publication-title: Angew Chem Int Ed Engl
– volume: 17
  start-page: 3
  issue: 1
  year: 2019
  end-page: 14
  article-title: An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota
  publication-title: Chin J Nat Med
– volume: 9
  start-page: 90
  year: 2019
  article-title: The gut microbiome signatures discriminate healthy from pulmonary tuberculosis patients
  publication-title: Front Cell Infect Microbiol
– volume: 1238
  start-page: 55
  year: 2020
  end-page: 72
  article-title: Gut microbiota and lung injury
  publication-title: Adv Exp Med Biol
– volume: 23
  start-page: 162
  issue: 1
  year: 2023
  article-title: Recent advances in non‐small cell lung cancer targeted therapy; an update review
  publication-title: Cancer Cell Int
– volume: 20
  start-page: 4742
  issue: 22
  year: 2016
  end-page: 4749
  article-title: The role of diet on gut microbiota composition
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 29
  start-page: 46830
  issue: 31
  year: 2022
  end-page: 46847
  article-title: Berberine‐loaded liquid crystalline nanoparticles inhibit non‐small cell lung cancer proliferation and migration in vitro
  publication-title: Environ Sci Pollut Res
– volume: 16
  start-page: 1210
  issue: 11
  year: 2010
  end-page: 1214
  article-title: The benefits and limitations of animal models for translational research in neurodegenerative diseases
  publication-title: Nat Med
– volume: 14
  year: 2023
  article-title: Epigenetic regulation of stem cells in lung cancer oncogenesis and therapy resistance
  publication-title: Front Genet
– volume: 18
  start-page: 97
  year: 2019
  article-title: The microbiota and microbiome in pancreatic cancer: more influential than expected
  publication-title: Mol Cancer
– volume: 11
  start-page: 227
  issue: 4
  year: 2013
  end-page: 238
  article-title: The gut microbiota—masters of host development and physiology
  publication-title: Nat Rev Microbiol
– volume: 76
  start-page: 473
  issue: 3
  year: 2019
  end-page: 493
  article-title: An insight into gut microbiota and its functionalities
  publication-title: Cell Mol Life Sci
– volume: 20
  start-page: 272
  issue: 1
  year: 2019
  article-title: Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety
  publication-title: Respir Res
– volume: 79
  start-page: 5999
  issue: 23
  year: 2019
  end-page: 6009
  article-title: Gastrointestinal tract dysbiosis enhances distal tumor progression through suppression of leukocyte trafficking
  publication-title: Cancer Res
– volume: 132
  issue: 4
  year: 2022
  article-title: Colorectal cancer: the facts in the case of the microbiota
  publication-title: J Clin Invest
– volume: 9
  start-page: 2047
  issue: 9
  year: 2019
  end-page: 2063
  article-title: The characterization of lung microbiome in lung cancer patients with different clinicopathology
  publication-title: Am J Cancer Res
– volume: 16
  start-page: 559
  issue: 5
  year: 2012
  end-page: 564
  article-title: Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk
  publication-title: Cell Metab
– volume: 371
  issue: 6536
  year: 2021
  article-title: The microbiome and human cancer
  publication-title: Science
– volume: 52
  start-page: 125
  issue: 1
  year: 2020
  end-page: 138
  article-title: Insights into gastrointestinal microbiota‐generated ginsenoside metabolites and their bioactivities
  publication-title: Drug Metab Rev
– volume: 350
  start-page: 2129
  issue: 21
  year: 2004
  end-page: 2139
  article-title: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non‐small‐cell lung cancer to gefitinib
  publication-title: N Engl J Med
– volume: 218
  start-page: 394
  year: 2022
  end-page: 408
  article-title: Structure‐guided design and development of cyclin‐dependent kinase 4/6 inhibitors: a review on therapeutic implications
  publication-title: Int J Biol Macromol
– volume: 20
  start-page: 1569
  issue: 2
  year: 2019
  end-page: 1574
  article-title: Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer
  publication-title: Mol Med Rep
– volume: 28
  issue: 4
  year: 2023
  article-title: Lipopolysaccharide (LPS) extracted from Bacteroides vulgatus effectively prevents LPS extracted from Escherichia coli from inducing epithelial‑mesenchymal transition
  publication-title: Mol Med Rep
– volume: 46
  start-page: 52
  issue: 1
  year: 2016
  end-page: 59
  article-title: Mechanisms of intestinal barrier dysfunction in sepsis
  publication-title: Shock
– volume: 61
  start-page: 160
  issue: 2
  year: 2012
  end-page: 174
  article-title: Probiotic mechanisms of action
  publication-title: Ann Nutr Metab
– volume: 8
  start-page: 1236
  issue: 10
  year: 2020
  end-page: 1242
  article-title: Association of probiotic Clostridium butyricum therapy with survival and response to immune checkpoint blockade in patients with lung cancer
  publication-title: Cancer Immunol Res
– volume: 77
  start-page: 2739
  issue: 14
  year: 2020
  end-page: 2749
  article-title: The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy
  publication-title: Cell Mol Life Sci
– volume: 1
  start-page: 497
  issue: 7
  year: 2010
  end-page: 514
  article-title: EGFR‐mutated lung cancer: a paradigm of molecular oncology
  publication-title: Oncotarget
– volume: 15
  year: 2024
  article-title: Gut microbiota and dietary intervention: affecting immunotherapy efficacy in non‐small cell lung cancer
  publication-title: Front Immunol
– volume: 5
  start-page: 423
  issue: 1
  year: 2015
  end-page: 432
  article-title: A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients
  publication-title: Am J Cancer Res
– volume: 9
  start-page: 1835
  year: 2018
  article-title: The human gut microbiome—a potential controller of wellness and disease
  publication-title: Front Microbiol
– volume: 12
  start-page: 66
  issue: 1
  year: 2021
  end-page: 78
  article-title: Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer
  publication-title: Thorac Cancer
– year: 2024
  publication-title: Immunotherapy Against Lung Cancer Emerging Opportunities and Challenges
– volume: 48
  start-page: 5798
  issue: 32
  year: 2009
  end-page: 5808
  article-title: The search for infectious causes of human cancers: where and why (Nobel lecture)
  publication-title: Angew Chem Int Ed Engl
– volume: 4
  start-page: 2020
  issue: 11
  year: 2019
  end-page: 2020
  article-title: Elevated faecal 12,13‐diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance (vol 4, pg 1851, 2019)
  publication-title: Nat Microbiol
– volume: 9
  issue: 1
  year: 2019
  article-title: Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma
  publication-title: Sci Rep
– volume: 11
  start-page: 301
  year: 2020
  article-title: The cross‐talk between gut microbiota and lungs in common lung diseases
  publication-title: Front Microbiol
– volume: 341
  start-page: 284
  issue: 5
  year: 2018
  end-page: 289
  article-title: The impact of the intestinal microbiota in therapeutic responses against cancer
  publication-title: C R Biol
– volume: 145
  start-page: 396
  issue: 2
  year: 2013
  end-page: 406
  article-title: Short‐chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice
  publication-title: Gastroenterology
– volume: 4
  start-page: 1851
  issue: 11
  year: 2019
  end-page: 1861
  article-title: Elevated faecal 12,13‐diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance
  publication-title: Nat Microbiol
– volume: 11
  year: 2021
  article-title: Immunotherapy in non‐small cell lung cancer with actionable mutations other than EGFR
  publication-title: Front Oncol
– volume: 27
  start-page: 2004
  issue: 11
  year: 2016
  end-page: 2016
  article-title: Predictors of chemotherapy efficacy in non‐small‐cell lung cancer: a challenging landscape
  publication-title: Ann Oncol
– volume: 12
  start-page: 1841
  issue: 2
  year: 2023
  end-page: 1849
  article-title: Impact of probiotics use on clinical outcomes of immune checkpoint inhibitors therapy in cancer patients
  publication-title: Cancer Med
– volume: 25
  start-page: 6487
  issue: 21
  year: 2019
  end-page: 6500
  article-title: Microbiota‐ and radiotherapy‐induced gastrointestinal side‐effects (MARS) study: a large pilot study of the microbiome in acute and late‐radiation enteropathy
  publication-title: Clin Cancer Res
– volume: 8
  issue: 12
  year: 2012
  article-title: Chapter 12: human microbiome analysis
  publication-title: PLoS Comput Biol
– volume: 102
  start-page: 757
  issue: 5
  year: 2017
  end-page: 764
  article-title: Current landscape of targeted therapy in lung cancer
  publication-title: Clin Pharmacol Ther
– volume: 54
  start-page: 3723
  issue: 14
  year: 1994
  end-page: 3725
  article-title: Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea
  publication-title: Cancer Res
– volume: 22
  start-page: 1238
  issue: 9
  year: 2015
  end-page: 1249
  article-title: Structure and inhibition of microbiome beta‐glucuronidases essential to the alleviation of cancer drug toxicity
  publication-title: Chem Biol
– volume: 25
  start-page: 275
  issue: 6
  year: 2022
  end-page: 290
  article-title: Astragalus polysaccharide alleviates constipation in the elderly via modification of gut microbiota and fecal metabolism
  publication-title: Rejuvenation Res
– volume: 7
  start-page: 488
  issue: 6
  year: 2021
  end-page: 495
  article-title: How comorbidities shape cancer biology and survival
  publication-title: Trends Cancer
– volume: 24
  start-page: 392
  issue: 4
  year: 2018
  end-page: 400
  article-title: Current understanding of the human microbiome
  publication-title: Nat Med
– volume: 130
  start-page: 255
  issue: 2
  year: 2014
  end-page: 267
  article-title: PI3K‐p110‐alpha‐subtype signalling mediates survival, proliferation and neurogenesis of cortical progenitor cells via activation of mTORC2
  publication-title: J Neurochem
– volume: 12
  issue: 556
  year: 2020
  article-title: Lung and gut microbiota are altered by hyperoxia and contribute to oxygen‐induced lung injury in mice
  publication-title: Sci Transl Med
– volume: 87
  start-page: 1158
  issue: 10
  year: 2016
  end-page: 1164
  article-title: Periodontal disease and incident lung cancer risk: a meta‐analysis of cohort studies
  publication-title: J Periodontol
– volume: 14
  start-page: 129
  issue: 1
  year: 2023
  article-title: Veillonella parvula promotes the proliferation of lung adenocarcinoma through the nucleotide oligomerization domain 2/cellular communication network factor 4/nuclear factor kappa B pathway
  publication-title: Discov Oncol
– volume: 26
  start-page: 154
  year: 2006
  end-page: 158
  article-title: The toxins of William B. Coley and the treatment of bone and soft‐tissue sarcomas
  publication-title: Iowa Orthop J
– volume: 6
  start-page: 97
  year: 2014
  article-title: MyD88: a central player in innate immune signaling
  publication-title: F1000Prime Rep
– volume: 152
  start-page: 73
  issue: 1
  year: 2011
  end-page: 75
  article-title: Comparative analysis of esterase activities of human, mouse, and rat blood
  publication-title: Bull Exp Biol Med
– volume: 213
  start-page: 404
  year: 2022
  end-page: 415
  article-title: A monomeric polysaccharide from Polygonatum sibiricum improves cognitive functions in a model of Alzheimer's disease by reshaping the gut microbiota
  publication-title: Int J Biol Macromol
– volume: 6
  issue: 2
  year: 2021
  article-title: The case for brachytherapy: why it deserves a renaissance
  publication-title: Adv Radiat Oncol
– volume: 4
  start-page: 120
  year: 2015
  end-page: 123
  article-title: Registered report: intestinal inflammation targets cancer‐inducing activity of the microbiota
  publication-title: eLife
– volume: 15
  start-page: 182
  issue: 2
  year: 2024
  end-page: 191
  article-title: Oral compound probiotic supplements can improve the quality of life for patients with lung cancer during chemotherapy: a randomized placebo‐controlled study
  publication-title: Thorac Cancer
– volume: 15
  start-page: 2809
  issue: 12
  year: 2016
  end-page: 2824
  article-title: Dietary fiber and bacterial SCFA enhance oral tolerance and protect against food allergy through diverse cellular pathways
  publication-title: Cell Rep
– volume: 9
  start-page: 223
  issue: 2
  year: 2018
  article-title: Modeling radiation injury‐induced cell death and countermeasure drug responses in a human gut‐on‐a‐chip
  publication-title: Cell Death Dis
– volume: 46
  start-page: 549
  issue: 4
  year: 2017
  end-page: 561
  article-title: Lung homeostasis: influence of age, microbes, and the immune system
  publication-title: Immunity
– volume: 7
  start-page: 907
  issue: 10
  year: 2019
  end-page: 920
  article-title: Functional effects of the microbiota in chronic respiratory disease
  publication-title: Lancet Respir Med
– volume: 359
  start-page: 91
  issue: 6371
  year: 2018
  end-page: 97
  article-title: Gut microbiome influences efficacy of PD‐1‐based immunotherapy against epithelial tumors
  publication-title: Science
– volume: 12
  start-page: 4347
  issue: 8
  year: 2020
  end-page: 4356
  article-title: The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non‐small cell lung cancer receiving chemoradiotherapy
  publication-title: J Thorac Dis
– volume: 153
  year: 2022
  article-title: Oral sodium butyrate supplementation ameliorates paclitaxel‐induced behavioral and intestinal dysfunction
  publication-title: Biomed Pharmacother
– volume: 82
  start-page: 179
  issue: 3
  year: 2019
  end-page: 189
  article-title: Chemotherapy for lung cancer in the era of personalized medicine
  publication-title: Tuberc Respir Dis (Seoul)
– volume: 13
  start-page: 607
  issue: 6
  year: 2012
  end-page: 615
  article-title: Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
  publication-title: Lancet Oncol
– volume: 3
  start-page: E969
  issue: 12
  year: 2022
  end-page: E983
  article-title: The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly
  publication-title: Lancet Microbe
– volume: 40
  start-page: 88
  issue: 3
  year: 2023
  article-title: Chemotherapy: how to reduce its adverse effects while maintaining the potency?
  publication-title: Med Oncol
– volume: 5
  start-page: 521
  issue: 4
  year: 2017
  end-page: 525
  article-title: An overview on radiotherapy: from its history to its current applications in dermatology
  publication-title: Open Access Maced J Med Sci
– year: 2023
  article-title: Engineered exosomes for cancer theranostics: next‐generation tumor targeting
  publication-title: J Drug Deliv Sci Technol
– volume: 48
  start-page: 992
  issue: 5
  year: 2018
  end-page: 1005
  article-title: Dietary fiber confers protection against flu by shaping Ly6c(‐) patrolling monocyte hematopoiesis and CD8(+) T cell metabolism
  publication-title: Immunity
– volume: 11
  start-page: 357
  year: 2020
  article-title: Intestinal dysbiosis and the developing lung: the role of toll‐like receptor 4 in the gut‐lung axis
  publication-title: Front Immunol
– volume: 12
  start-page: 86
  issue: 1
  year: 2022
  article-title: Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non‐small cell lung cancer
  publication-title: AMB Expr
– volume: 313
  year: 2023
  article-title: Corrigendum to: “Hypoglycemic effect of astragaloside IV via modulating gut microbiota and regulating AMPK/SIRT1 and PI3K/AKT pathway” [J. Ethnopharmacol. 281 (2021) 114558]
  publication-title: J Ethnopharmacol
– volume: 6
  start-page: 291
  issue: 1
  year: 2021
  article-title: Pattern recognition receptors in health and diseases
  publication-title: Signal Transduct Target Ther
– volume: 17
  start-page: 163
  issue: 1
  year: 2016
  article-title: Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features
  publication-title: Genome Biol
– volume: 7
  start-page: 135
  issue: 1
  year: 2022
  article-title: Microbiota in health and diseases
  publication-title: Signal Transduct Target Ther
– volume: 20
  start-page: 672
  issue: 4
  year: 2011
  end-page: 678
  article-title: Increased risk of lung cancer in men with tuberculosis in the alpha‐tocopherol, beta‐carotene cancer prevention study
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 14
  start-page: 5405
  issue: 21
  year: 2022
  article-title: Cancer cachexia among patients with advanced non‐small‐cell lung cancer on immunotherapy: an observational study with exploratory gut microbiota analysis
  publication-title: Cancers
– volume: 466
  start-page: 334
  issue: 7304
  year: 2010
  end-page: U81
  article-title: Viruses in the faecal microbiota of monozygotic twins and their mothers
  publication-title: Nature
– volume: 2014
  year: 2014
  article-title: Role of microbiota and innate immunity in recurrent Clostridium difficile infection
  publication-title: J Immunol Res
– volume: 154
  start-page: 154
  issue: 1
  year: 2018
  end-page: 167
  article-title: Intestinal dysbiosis featuring abundance of Ruminococcus gnavus associates with allergic diseases in infants
  publication-title: Gastroenterology
– volume: 14
  issue: 1
  year: 2018
  article-title: Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children
  publication-title: PLoS Pathog
– volume: 5
  start-page: 3111
  issue: 10
  year: 2015
  end-page: 3122
  article-title: Discovery and validation of potential bacterial biomarkers for lung cancer
  publication-title: Am J Cancer Res
– volume: 5
  start-page: 987
  issue: 10
  year: 2004
  end-page: 995
  article-title: Toll‐like receptor control of the adaptive immune responses
  publication-title: Nat Immunol
– volume: 9
  start-page: 374
  year: 2018
  article-title: Modulation of gut microbiota: a novel paradigm of enhancing the efficacy of programmed death‐1 and programmed death ligand‐1 blockade therapy
  publication-title: Front Immunol
– volume: 14
  start-page: 1378
  issue: 8
  year: 2019
  end-page: 1389
  article-title: The diversity of gut microbiome is associated with favorable responses to anti‐programmed death 1 immunotherapy in chinese patients with NSCLC
  publication-title: J Thorac Oncol
– volume: 25
  start-page: 4051
  issue: 7
  year: 2024
  article-title: Microbiota and immunity during respiratory infections: lung and gut affair
  publication-title: Int J Mol Sci
– volume: 118
  year: 2019
  article-title: Irisin alleviates pulmonary epithelial barrier dysfunction in sepsis‐induced acute lung injury via activation of AMPK/SIRT1 pathways
  publication-title: Biomed Pharmacother
– volume: 22
  start-page: 898
  issue: 5
  year: 2017
  end-page: 904
  article-title: Oral administration of Clostridium butyricum CGMCC0313‐1 reduces ovalbumin‐induced allergic airway inflammation in mice
  publication-title: respirol
– volume: 12
  year: 2022
  article-title: Tumor microbiome—an integral part of the tumor microenvironment
  publication-title: Front Oncol
– volume: 102
  start-page: 89
  year: 2016
  end-page: 95
  article-title: Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions
  publication-title: Lung Cancer
– volume: 19
  start-page: 77
  issue: 2
  year: 2021
  end-page: 94
  article-title: Gut microbial metabolites as multi‐kingdom intermediates
  publication-title: Nat Rev Micro
– volume: 384
  start-page: 691
  issue: 9944
  year: 2014
  end-page: 702
  article-title: The role of the microbiome in exacerbations of chronic lung diseases
  publication-title: Lancet
– volume: 23
  start-page: 31
  issue: 1
  year: 2021
  end-page: 41
  article-title: Changes in gut microbiome associated with co‐occurring symptoms development during chemo‐radiation for rectal cancer: a proof of concept study
  publication-title: Biol Res Nurs
– volume: 16
  start-page: 1024
  issue: 7
  year: 2014
  end-page: 1033
  article-title: Defining dysbiosis and its influence on host immunity and disease
  publication-title: Cell Microbiol
– volume: 18
  start-page: 884
  issue: 12
  year: 2011
  end-page: 896
  article-title: Antitumor effect of sFlt‐1 gene therapy system mediated by Bifidobacterium Infantis on Lewis lung cancer in mice
  publication-title: Cancer Gene Ther
– volume: 136
  start-page: 129
  year: 2019
  end-page: 135
  article-title: Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: a multiple comparative study design with independent validation
  publication-title: Lung Cancer
– volume: 161
  start-page: 419
  issue: 2
  year: 2021
  end-page: 429
  article-title: Lower airway bacterial microbiome may influence recurrence after resection of early‐stage non‐small cell lung cancer
  publication-title: J Thorac Cardiovasc Surg
– volume: 16
  start-page: 9
  issue: 1
  year: 2021
  article-title: Radiotherapy and the gut microbiome: facts and fiction
  publication-title: Radiat Oncol
– volume: 100
  start-page: 943
  issue: 5
  year: 2016
  end-page: 950
  article-title: A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs
  publication-title: J Leukocyte Biol
– volume: 51
  start-page: 4187
  issue: 16
  year: 1991
  end-page: 4191
  article-title: Intracellular roles of SN‐38, a metabolite of the camptothecin derivative CPT‐11, in the antitumor effect of CPT‐11
  publication-title: Cancer Res
– volume: 149
  start-page: 1578
  issue: 7
  year: 2012
  end-page: 1593
  article-title: Gut immune maturation depends on colonization with a host‐specific microbiota
  publication-title: Cell
– volume: 23
  start-page: 2934
  issue: 16
  year: 2004
  end-page: 2949
  article-title: Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks
  publication-title: Oncogene
– volume: 10
  start-page: 9
  year: 2020
  article-title: The gut‐lung axis in health and respiratory diseases: a place for inter‐organ and inter‐kingdom crosstalks
  publication-title: Front Cell Infect Microbiol
– volume: 11
  start-page: 1621
  issue: 6
  year: 2020
  end-page: 1632
  article-title: Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients
  publication-title: Thorac Cancer
– volume: 12
  start-page: 6325
  issue: 5
  year: 2023
  end-page: 6336
  article-title: Bifidobacterium breve predicts the efficacy of anti‐PD‐1 immunotherapy combined with chemotherapy in Chinese NSCLC patients
  publication-title: Cancer Med
– volume: 27
  start-page: 3052
  issue: 8
  year: 2020
  end-page: 3063
  article-title: Clinicopathologic features and genetic alterations in adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: long‐term follow‐up study of 121 Asian patients
  publication-title: Ann Surg Oncol
– volume: 8
  start-page: 69
  issue: 1
  year: 2020
  article-title: Gut microbiota‐derived indole 3‐propionic acid protects against radiation toxicity via retaining acyl‐CoA‐binding protein
  publication-title: Microbiome
– volume: 61
  start-page: 267
  issue: 4
  year: 2021
  end-page: 292
  article-title: Microbial, environmental and anthropogenic factors influencing the indoor microbiome of the built environment
  publication-title: J Basic Microbiol
– volume: 12
  start-page: 252
  issue: 4
  year: 2012
  end-page: 264
  article-title: The blockade of immune checkpoints in cancer immunotherapy
  publication-title: Nat Rev Cancer
– volume: 23
  start-page: 3747
  issue: 5
  year: 2019
  end-page: 3756
  article-title: Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy
  publication-title: J Cell Mol Med
– volume: 11
  start-page: 65
  issue: 1
  year: 2022
  article-title: Gut microbiota‐derived PGF2α fights against radiation‐induced lung toxicity through the MAPK/NF‐κB pathway
  publication-title: Antioxidants
– volume: 107
  start-page: 10
  issue: 1
  year: 2002
  end-page: 19
  article-title: Bugs as drugs for cancer
  publication-title: Immunology
– volume: 13
  start-page: 7903
  issue: 1
  year: 2022
  article-title: Design of a self‐driven probiotic‐CRISPR/Cas9 nanosystem for sono‐immunometabolic cancer therapy
  publication-title: Nat Commun
– volume: 18
  start-page: 2
  issue: 1
  year: 2017
  article-title: Role of intestinal microbiota and metabolites on gut homeostasis and human diseases
  publication-title: BMC Immunol
– volume: 10
  start-page: 360
  year: 2019
  article-title: Cross‐talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis
  publication-title: Front Immunol
– volume: 10
  start-page: 44
  issue: 2
  year: 2019
  article-title: Mycobacterium tuberculosis antigens repress Th1 immune response suppression and promotes lung cancer metastasis through PD‐1/PDl‐1 signaling pathway
  publication-title: Cell Death Dis
– volume: 31
  start-page: 124
  issue: 3
  year: 2020
  end-page: 134
  article-title: History of radiation therapy technology
  publication-title: Progress Med Phys
– volume: 198
  start-page: 1188
  issue: 9
  year: 2018
  end-page: 1198
  article-title: Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer
  publication-title: Am J Respir Crit Care Med
– volume: 102
  start-page: 13254
  issue: 37
  year: 2005
  end-page: 13259
  article-title: Microbial regulation of intestinal radiosensitivity
  publication-title: Proc Natl Acad Sci USA
– volume: 337
  start-page: 629
  year: 2021
  end-page: 644
  article-title: Recent trends of NFκB decoy oligodeoxynucleotide‐based nanotherapeutics in lung diseases
  publication-title: J Control Release
– volume: 14
  year: 2023
  article-title: Soluble biomarkers to predict clinical outcomes in non‐small cell lung cancer treated by immune checkpoints inhibitors
  publication-title: Front Immunol
– volume: 55
  start-page: 643
  issue: 8
  year: 2014
  end-page: 651
  article-title: The potential role of lung microbiota in lung cancer attributed to household coal burning exposures
  publication-title: Environ Mol Mutagen
– volume: 350
  start-page: 1084
  issue: 6264
  year: 2015
  end-page: 1089
  article-title: Commensal Bifidobacterium promotes antitumor immunity and facilitates anti‐PD‐L1 efficacy
  publication-title: Science
– volume: 5
  start-page: 1638
  issue: 9
  year: 2023
  article-title: Author Correction: the gut microbial metabolite formate exacerbates colorectal cancer progression
  publication-title: Nat Metab
– volume: 107
  start-page: 2637
  issue: 11
  year: 2006
  end-page: 2646
  article-title: Nuclear factor‐kappaB (NF‐kappaB) is frequently expressed in lung cancer and preneoplastic lesions
  publication-title: Cancer
– volume: 6
  issue: 2
  year: 2011
  article-title: Analysis of the lung microbiome in the “healthy” smoker and in COPD
  publication-title: PLoS One
– volume: 10
  start-page: 299
  issue: 2
  year: 2017
  end-page: 306
  article-title: The respiratory tract microbiome and lung inflammation: a two‐way street
  publication-title: Mucosal Immunol
– volume: 13
  start-page: 2008
  issue: 12
  year: 2021
  article-title: Recent advances in chronotherapy targeting respiratory diseases
  publication-title: Pharmaceutics
– volume: 150
  year: 2022
  article-title: Biomedical applications of metallic nanoparticles in cancer: current status and future perspectives
  publication-title: Biomed Pharmacother
– volume: 43
  start-page: 357
  issue: 5
  year: 2016
  end-page: 365
  article-title: Klotho deficiency aggravates tacrolimus‐induced renal injury via the phosphatidylinositol 3‐kinase‐Akt‐forkhead box protein O pathway
  publication-title: Am J Nephrol
– volume: 14
  year: 2023
  article-title: Gut microbiome and serum short‐chain fatty acids are associated with responses to chemo‐ or targeted therapies in Chinese patients with lung cancer
  publication-title: Front Microbiol
– volume: 3
  start-page: 402
  issue: 4
  year: 2022
  end-page: 417
  article-title: An allosteric inhibitor against the therapy‐resistant mutant forms of EGFR in non‐small cell lung cancer
  publication-title: Nat Cancer
– volume: 368
  start-page: 973
  issue: 6494
  year: 2020
  end-page: 980
  article-title: The human tumor microbiome is composed of tumor type‐specific intracellular bacteria
  publication-title: Science
– volume: 21
  start-page: 1616
  issue: 10
  year: 2011
  end-page: 1625
  article-title: The human gut virome: inter‐individual variation and dynamic response to diet
  publication-title: Genome Res
– volume: 9
  year: 2021
  article-title: New approaches and procedures for cancer treatment: current perspectives
  publication-title: SAGE Open Med
– volume: 8
  start-page: 411
  issue: 6
  year: 2008
  end-page: 420
  article-title: Epithelial‐cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut
  publication-title: Nat Rev Immunol
– volume: 19
  start-page: 253
  year: 2018
  article-title: Effects of smoking on the lower respiratory tract microbiome in mice
  publication-title: Respir Res
– volume: 342
  start-page: 967
  issue: 6161
  year: 2013
  end-page: 970
  article-title: Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment
  publication-title: Science
– volume: 178
  start-page: 2000
  issue: 4
  year: 2007
  end-page: 2007
  article-title: Distinct differentiation potential of blood monocyte subsets in the lung
  publication-title: J Immunol
– volume: 28
  start-page: 3138
  issue: 19
  year: 2010
  end-page: 3145
  article-title: Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early‐stage non‐small‐cell lung cancer
  publication-title: J Clin Oncol
– volume: 187
  start-page: 973
  issue: 5
  year: 2017
  end-page: 979
  article-title: Nontypeable haemophilus influenzae‐promoted proliferation of kras‐induced early adenomatous lesions is completely dependent on toll‐like receptor signaling
  publication-title: Am J Pathol
– volume: 157
  start-page: 362
  issue: 1
  year: 2019
  end-page: 373
  article-title: A systematic review and meta‐analysis of stereotactic body radiation therapy versus surgery for patients with non‐small cell lung cancer
  publication-title: J Thorac Cardiovasc Surg
– volume: 11
  start-page: 385
  issue: 5
  year: 2019
  end-page: 396
  article-title: Intestinal microbiota predicts lung cancer patients at risk of immune‐related diarrhea
  publication-title: Immunotherapy
– volume: 1
  start-page: 109
  issue: 2
  year: 2018
  end-page: 115
  article-title: The role of the gut microbiota on animal model reproducibility
  publication-title: Animal Model Exp Med
– volume: 13
  start-page: 270
  issue: 4
  year: 2022
  end-page: 286
  article-title: Microbiome in precision psychiatry: an overview of the ethical challenges regarding microbiome big data and microbiome‐based interventions
  publication-title: AJOB Neurosci
– volume: 28
  start-page: 19
  issue: 1
  year: 1999
  end-page: 25
  article-title: Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery
  publication-title: J Pediatr Gastroenterol Nutr
– volume: 235
  year: 2020
  article-title: Cultured Cordyceps sinensis polysaccharides modulate intestinal mucosal immunity and gut microbiota in cyclophosphamide‐treated mice
  publication-title: Carbohydr Polym
– volume: 75
  start-page: 1059
  issue: 12
  year: 2017
  end-page: 1080
  article-title: Interindividual variability in gut microbiota and host response to dietary interventions
  publication-title: Nutr Rev
– volume: 193
  start-page: 116
  issue: 2
  year: 2016
  end-page: 130
  article-title: Macrophages, inflammation, and lung cancer
  publication-title: Am J Respir Crit Care Med
– volume: 361
  start-page: 512
  issue: 9356
  year: 2003
  end-page: 519
  article-title: Gut flora in health and disease
  publication-title: Lancet
– volume: 164
  start-page: 1233
  issue: 6
  year: 2016
  end-page: 1247
  article-title: The basis of oncoimmunology
  publication-title: Cell
– volume: 88
  start-page: 494
  issue: 3
  year: 2013
  end-page: 503
  article-title: Lung cancer in never smokers: disease characteristics and risk factors
  publication-title: Crit Rev Oncol Hematol
– volume: 17
  start-page: 1308
  issue: 6
  year: 2008
  end-page: 1315
  article-title: Antibiotic use and the risk of lung cancer
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 23
  start-page: 2149
  issue: 12
  year: 2017
  end-page: 2158
  article-title: Protective effect of Bifidobacterium infantis CGMCC313‐2 on ovalbumin‐induced airway asthma and beta‐lactoglobulin‐induced intestinal food allergy mouse models
  publication-title: World J Gastroenterol
– year: 2023
  article-title: Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases
  publication-title: Chem Biol Interact
– volume: 149
  start-page: 473
  issue: 2
  year: 2021
  end-page: 482
  article-title: Clinical impact of probiotics on the efficacy of anti‐PD‐1 monotherapy in patients with nonsmall cell lung cancer: a multicenter retrospective survival analysis study with inverse probability of treatment weighting
  publication-title: Int J Cancer
– volume: 4
  start-page: 89
  issue: 3
  year: 2020
  end-page: 98
  article-title: Low dose rate permanent seed brachytherapy: tracing its evolution and current status
  publication-title: Precis Radiat Oncol
– volume: 19
  start-page: 123
  issue: 1
  year: 2018
  article-title: Interaction between the microbiome and TP53 in human lung cancer
  publication-title: Genome Biol
– volume: 107
  issue: 10
  year: 2015
  article-title: Circulating inflammation markers, risk of lung cancer, and utility for risk stratification
  publication-title: J Natl Cancer Inst
– volume: 5
  start-page: 1313
  year: 2022
  end-page: 1319
  article-title: Spirulina polysaccharide induces the metabolic shifts and gut microbiota change of lung cancer in mice
  publication-title: Curr Res Food Sci
– volume: 67
  start-page: 97
  issue: 1
  year: 2018
  end-page: 107
  article-title: Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction
  publication-title: Gut
– volume: 102
  start-page: 1197
  issue: 5
  year: 2007
  end-page: 1208
  article-title: Understanding the effects of diet on bacterial metabolism in the large intestine
  publication-title: J Appl Microbiol
– volume: 12
  issue: 5
  year: 2017
  article-title: A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer
  publication-title: PLoS One
– volume: 3
  start-page: 205
  issue: 4
  year: 2014
  end-page: 211
  article-title: Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations
  publication-title: Transl Lung Cancer Res
– volume: 9
  start-page: 1554
  issue: 4
  year: 2020
  end-page: 1568
  article-title: Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms
  publication-title: Transl Lung Cancer Res
– volume: 238
  year: 2022
  article-title: The critical role of short‐chain fatty acids in health and disease: a subtle focus on cardiovascular disease‐NLRP3 inflammasome‐angiogenesis axis
  publication-title: Clin Immunol
– volume: 27
  start-page: 1345
  issue: 8
  year: 2021
  end-page: 1356
  article-title: Toward personalized treatment approaches for non‐small‐cell lung cancer
  publication-title: Nat Med
– volume: 16
  start-page: 553
  issue: 9
  year: 2016
  end-page: 565
  article-title: Pancreatic cancer biology and genetics from an evolutionary perspective
  publication-title: Nat Rev Cancer
– volume: 6
  start-page: 137
  year: 2011
  article-title: Bacterial and fungal microflora in surgically removed lung cancer samples
  publication-title: J Cardiothorac Surg
– volume: 24
  year: 2020
  article-title: Breast cancer: lifestyle, the human gut microbiota/microbiome, and survivorship
  publication-title: Perm J
– volume: 6
  start-page: 6734
  year: 2015
  article-title: Metabolite‐sensing receptors GPR43 and GPR109A facilitate dietary fibre‐induced gut homeostasis through regulation of the inflammasome
  publication-title: Nat Commun
– volume: 912
  year: 2021
  article-title: Sinomenine ameliorates septic acute lung injury in mice by modulating gut homeostasis via aryl hydrocarbon receptor/Nrf2 pathway
  publication-title: Eur J Pharmacol
– volume: 164
  year: 2021
  article-title: Exploring the role of respiratory microbiome in lung cancer: a systematic review
  publication-title: Crit Rev Oncol Hematol
– volume: 8
  start-page: 28
  issue: 1
  year: 2020
  article-title: Predictable modulation of cancer treatment outcomes by the gut microbiota
  publication-title: Microbiome
– volume: 14
  year: 2023
  article-title: Stenotrophomonas maltophilia promotes lung adenocarcinoma progression by upregulating histone deacetylase 5
  publication-title: Front Microbiol
– volume: 12
  start-page: 567
  issue: 7
  year: 2020
  end-page: 570
  article-title: Recent advances in experimental animal models of lung cancer
  publication-title: Future Med Chem
– volume: 52
  start-page: 721
  issue: Pt 8
  year: 2003
  end-page: 726
  article-title: Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case‐control study
  publication-title: J Med Microbiol
– volume: 383
  start-page: 640
  issue: 7
  year: 2020
  end-page: 649
  article-title: The effect of advances in lung‐cancer treatment on population mortality
  publication-title: N Engl J Med
– volume: 21
  start-page: 560
  issue: 6
  year: 2015
  end-page: 562
  article-title: Acquired EGFR C797S mutation mediates resistance to AZD9291 in non‐small cell lung cancer harboring EGFR T790M
  publication-title: Nat Med
– volume: 28
  start-page: 690
  issue: 4
  year: 2022
  end-page: 703
  article-title: Targeting the gut and tumor microbiota in cancer
  publication-title: Nat Med
– volume: 14
  start-page: 5642
  issue: 2
  year: 2015
  end-page: 5651
  article-title: Well‐balanced commensal microbiota contributes to anti‐cancer response in a lung cancer mouse model
  publication-title: Genet Mol Res
– volume: 6
  issue: 2
  year: 2015
  article-title: Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals
  publication-title: mBio
– volume: 125
  start-page: 2936
  issue: 12
  year: 2009
  end-page: 2944
  article-title: Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review
  publication-title: Int J Cancer
– volume: 11
  year: 2021
  article-title: Beneficial effect of alkaloids from Sophora alopecuroides L. on CUMS‐induced depression model mice via modulating gut microbiota
  publication-title: Front Cell Infect Microbiol
– volume: 49
  start-page: 973
  issue: 4
  year: 2001
  end-page: 985
  article-title: Estimating the need for radiotherapy for lung cancer: an evidence‐based, epidemiologic approach
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 30
  start-page: 105
  issue: 1
  year: 2024
  article-title: Microbiome in radiotherapy: an emerging approach to enhance treatment efficacy and reduce tissue injury
  publication-title: Mol Med
– year: 2023
  article-title: Propionate reinforces epithelial identity and reduces aggressiveness of non‐small cell lung carcinoma via chromatin remodelling
  publication-title: Biorxiv
– volume: 6
  start-page: 205
  issue: 4
  year: 1946
  end-page: 216
  article-title: The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, MD, reviewed in the light of modern research
  publication-title: Cancer Res
– volume: 11
  year: 2020
  article-title: Organ‐specific effects of low dose radiation exposure: a comprehensive review
  publication-title: Front Genet
– volume: 2017
  year: 2017
  article-title: Desired turbulence? gut‐lung axis, immunity, and lung cancer
  publication-title: J Oncol
– volume: 6
  start-page: 121
  issue: 3
  year: 2017
  end-page: 130
  article-title: Interaction between diet composition and gut microbiota and its impact on gastrointestinal tract health
  publication-title: Food Sci Hum Wellness
– volume: 43
  start-page: 193
  issue: 2
  year: 2007
  end-page: 198
  article-title: High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA‐based immunohistochemical analysis
  publication-title: Oral Oncol
– start-page: 1
  year: 2022
  end-page: 22
  article-title: Kinase inhibitors: an overview
  publication-title: Protein Kinase Inhibitors
– volume: 11
  issue: 7
  year: 2015
  article-title: The lung microbiome: new principles for respiratory bacteriology in health and disease
  publication-title: PLoS Pathog
– volume: 102
  start-page: 2880
  issue: 8
  year: 2005
  end-page: 2885
  article-title: Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization
  publication-title: Proc Natl Acad Sci USA
– volume: 8
  start-page: 201
  issue: 1
  year: 2023
  article-title: Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
  publication-title: Signal Transd Target Ther
– volume: 15
  start-page: 168
  issue: 1
  year: 2023
  article-title: Lipopolysaccharide and lipoteichoic acid regulate the PI3K/AKT pathway through osteopontin/integrin β3 to promote malignant progression of non‐small cell lung cancer
  publication-title: J Thorac Dis
– volume: 13
  start-page: 13
  issue: 1
  year: 2020
  article-title: The lung microbiome: a central mediator of host inflammation and metabolism in lung cancer patients?
  publication-title: Cancers (Basel)
– volume: 8
  start-page: 375
  issue: 4
  year: 2014
  end-page: 381
  article-title: Epidemiology of active tuberculosis in lung cancer patients: a systematic review
  publication-title: Clin Respir J
– volume: 57
  start-page: 1
  issue: 1
  year: 2018
  end-page: 24
  article-title: Gut microbiota functions: metabolism of nutrients and other food components
  publication-title: Eur J Nutr
– volume: 35
  start-page: 199
  year: 2017
  end-page: 228
  article-title: Microbes and cancer
  publication-title: Annu Rev Immunol
– volume: 32
  year: 2023
  article-title: G protein‐coupled receptors: a target for microbial metabolites and a mechanistic link to microbiome‐immune‐brain interactions
  publication-title: Brain Behav Immun Health
– volume: 11
  issue: 10
  year: 2019
  article-title: Celiac disease and the microbiome
  publication-title: Nutrients
– volume: 288
  start-page: G696
  issue: 4
  year: 2005
  end-page: G704
  article-title: Luminal bacterial flora determines physiological expression of intestinal epithelial cytoprotective heat shock proteins 25 and 72
  publication-title: Am J Physiol Gastrointest Liver Physiol
– volume: 21
  start-page: 658
  issue: 9
  year: 2018
  end-page: 662
  article-title: Helicobacter pylori infection and lung cancer: New insights and future challenges
  publication-title: Zhongguo Fei Ai Za Zhi
– volume: 16
  start-page: 275
  issue: 5
  year: 2016
  end-page: 287
  article-title: Mechanism‐driven biomarkers to guide immune checkpoint blockade in cancer therapy
  publication-title: Nat Rev Cancer
– volume: 25
  start-page: 97
  issue: 139
  year: 2016
  end-page: 98
  article-title: Pulmonary tuberculosis masquerading as metastatic lung disease
  publication-title: Eur Respir Rev
– volume: 121
  start-page: 1935
  issue: 5
  year: 2011
  end-page: 1945
  article-title: Wnt/beta‐catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium
  publication-title: J Clin Invest
– volume: 16
  start-page: 731
  issue: 12
  year: 2020
  end-page: 739
  article-title: Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer
  publication-title: Nat Rev Endocrinol
– volume: 8
  start-page: 1741
  issue: 11
  year: 2020
  article-title: Bile acid signal molecules associate temporally with respiratory inflammation and microbiome signatures in clinically stable cystic fibrosis patients
  publication-title: Microorganisms
– volume: 137
  start-page: 771
  issue: 5
  year: 2011
  end-page: 778
  article-title: Evidence of the cross talk between Wnt and Notch signaling pathways in non‐small‐cell lung cancer (NSCLC): notch3‐siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines
  publication-title: J Cancer Res Clin Oncol
– volume: 24
  start-page: 611
  issue: 1
  year: 2020
  article-title: Antibiotic‐related gut dysbiosis induces lung immunodepression and worsens lung infection in mice
  publication-title: Crit Care
– volume: 65
  issue: 15
  year: 2021
  article-title: Propionate and butyrate produced by gut microbiota after probiotic supplementation attenuate lung metastasis of melanoma cells in mice
  publication-title: Mol Nutr Food Res
– volume: 31
  year: 2021
  article-title: Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: current status and future perspectives
  publication-title: Nanomed Nanotechnol Biol Med
– volume: 124
  start-page: 53
  year: 2018
  end-page: 64
  article-title: KRAS‐Mutant non‐small cell lung cancer: from biology to therapy
  publication-title: Lung Cancer
– volume: 12
  year: 2021
  article-title: Acute radiation syndrome and the microbiome: impact and review
  publication-title: Front Pharmacol
– start-page: 493
  year: 2020
  end-page: 516
– volume: 74
  start-page: 12
  issue: 1
  year: 2024
  end-page: 49
  article-title: Cancer statistics, 2024
  publication-title: CA Cancer J Clin
– volume: 105
  start-page: 28
  year: 2017
  end-page: 34
  article-title: Gut microbiota modulate host immune cells in cancer development and growth
  publication-title: Free Radic Biol Med
– volume: 71
  start-page: 734
  issue: 4
  year: 2022
  end-page: 745
  article-title: Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti‐PD‐1/PD‐L1) immunotherapy
  publication-title: Gut
– volume: 109
  start-page: S21
  issue: 2
  year: 2013
  end-page: S26
  article-title: Linking the gut microbiota to human health
  publication-title: Br J Nutr
– volume: 29
  start-page: 196
  year: 2015
  end-page: 207
  article-title: Engineering Bacillus subtilis for the conversion of the antimetabolite 4‐hydroxy‐l‐threonine to pyridoxine
  publication-title: Metab Eng
– volume: 18
  start-page: 571
  issue: 3
  year: 2001
  end-page: 588
  article-title: Lung mucosal immunity: immunoglobulin‐A revisited
  publication-title: Eur Respir J
– volume: 8
  start-page: e180
  issue: 2
  year: 2020
  end-page: e190
  article-title: Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
  publication-title: Lancet Glob Health
– volume: 6
  start-page: 86
  issue: 2
  year: 2020
  end-page: 97
  article-title: The influence of lung microbiota on lung carcinogenesis, immunity, and immunotherapy
  publication-title: Trends Cancer
– volume: 86
  start-page: 732
  issue: Pt 3
  year: 2022
  end-page: 742
  article-title: Microbiome dysbiosis and epigenetic modulations in lung cancer: from pathogenesis to therapy
  publication-title: Semin Cancer Biol
– volume: 47
  start-page: 1082
  issue: 4
  year: 2016
  end-page: 1092
  article-title: Lung microbiome dynamics in COPD exacerbations
  publication-title: Eur Respir J
– volume: 36
  start-page: 1549
  issue: 6
  year: 2017
  end-page: 1557
  article-title: Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates inflammatory response and homeostasis of spleen and colon in experimental model of Pseudomonas aeruginosa pneumonia
  publication-title: Clin Nutr
– volume: 187
  start-page: 1067
  issue: 10
  year: 2013
  end-page: 1075
  article-title: Comparison of the respiratory microbiome in healthy nonsmokers and smokers
  publication-title: Am J Respir Crit Care Med
– volume: 10
  year: 2020
  article-title: Pulmonary micro‐ecological changes and potential microbial markers in lung cancer patients
  publication-title: Front Oncol
– volume: 369
  year: 2023
  article-title: N‐(2‐hydroxyphenyl)‐2‐phenazinamine from Nocardiopsis exhalans induces p53‐mediated intrinsic apoptosis signaling in lung cancer cell lines
  publication-title: Chem Biol Interact
– volume: 11
  start-page: 645
  year: 2020
  article-title: The bacterium Akkermansia muciniphila: a sentinel for gut permeability and its relevance to HIV‐related inflammation
  publication-title: Front Immunol
– volume: 12
  start-page: 843
  issue: 4
  year: 2019
  end-page: 850
  article-title: Microbes, metabolites, and the gut‐lung axis
  publication-title: Mucosal Immunol
– volume: 4
  year: 2015
  article-title: Reproducibility Project: cancer B. Registered report: intestinal inflammation targets cancer‐inducing activity of the microbiota
  publication-title: eLife
– volume: 50
  start-page: 2199
  issue: 8
  year: 2022
  end-page: 2221
  article-title: Berberine attenuates hyperuricemia by regulating urate transporters and gut microbiota
  publication-title: Am J Chin Med
– volume: 187
  start-page: 1118
  issue: 10
  year: 2013
  end-page: 1126
  article-title: Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation
  publication-title: Am J Respir Crit Care Med
– volume: 36
  start-page: 616
  issue: 7
  year: 2020
  end-page: 633
  article-title: Environmental factors and host microbiomes shape host‐pathogen dynamics
  publication-title: Trends Parasitol
– volume: 91
  year: 2021
  article-title: Effect of gut microbiota on LPS‐induced acute lung injury by regulating the TLR4/NF‐kB signaling pathway
  publication-title: Int Immunopharmacol
– volume: 13
  year: 2022
  article-title: Human gut microbiota in health and disease: unveiling the relationship
  publication-title: Front Microbiol
– volume: 31
  start-page: 579
  issue: 5
  year: 2017
  end-page: 588
  article-title: The interaction between smoking, alcohol and the gut microbiome
  publication-title: Best Pract Res Clin Gastroenterol
– volume: 24
  issue: 14
  year: 2023
  article-title: How can the microbiome induce carcinogenesis and modulate drug resistance in cancer therapy?
  publication-title: Int J Mol Sci
– volume: 19
  start-page: 445
  issue: 1
  year: 2019
  article-title: Characterization of gut microbiota in children with pulmonary tuberculosis
  publication-title: BMC Pediatr
– volume: 11
  start-page: 65
  issue: 1
  year: 2021
  article-title: Gut microbiota‐derived PGF2alpha fights against radiation‐induced lung toxicity through the MAPK/NF‐kappaB pathway
  publication-title: Antioxidants (Basel)
– volume: 18
  start-page: 1185
  issue: 12
  year: 2012
  end-page: 1193
  article-title: Microbial culturomics: paradigm shift in the human gut microbiome study
  publication-title: Clin Microbiol Infect
– volume: 22
  start-page: 905
  issue: 5
  year: 2017
  end-page: 912
  article-title: Oral administration of Saccharomyces cerevisiae UFMG A‐905 prevents allergic asthma in mice
  publication-title: Respirology
– volume: 30
  start-page: 734
  issue: 6
  year: 2015
  end-page: 746
  article-title: Gut microbiome: what we do and don't know
  publication-title: Nutr Clin Pract
– volume: 176
  start-page: 2161
  issue: 4
  year: 2006
  end-page: 2172
  article-title: A major lung CD103 (alphaE)‐beta7 integrin‐positive epithelial dendritic cell population expressing Langerin and tight junction proteins
  publication-title: J Immunol
– volume: 13
  start-page: 1446
  issue: 8
  year: 2012
  end-page: 1473
  article-title: Bacteria and their toxins tamed for immunotherapy
  publication-title: Curr Pharm Biotechnol
– volume: 12
  year: 2021
  article-title: Adjunctive probiotic Lactobacillus rhamnosus Probio‐M9 administration enhances the effect of anti‐PD‐1 antitumor therapy via restoring antibiotic‐disrupted gut microbiota
  publication-title: Front Immunol
– volume: 160
  start-page: 258
  issue: 4
  year: 2012
  end-page: 266
  article-title: The microbiome of the lung
  publication-title: Transl Res
– volume: 20
  start-page: 624
  issue: 9
  year: 2023
  end-page: 639
  article-title: The global burden of lung cancer: current status and future trends
  publication-title: Nat Rev Clin Oncol
– volume: 136
  start-page: 310
  year: 2021
  end-page: 317
  article-title: Oral administration of Bacillus subtilis promotes homing of CD3(+) T cells and IgA‐secreting cells to the respiratory tract in piglets
  publication-title: Res Vet Sci
– volume: 11
  year: 2021
  article-title: Role and mechanism of gut microbiota in human disease
  publication-title: Front Cell Infect Microbiol
– volume: 12
  start-page: 426
  issue: 5
  year: 2021
  end-page: 435
  article-title: Unexpected guests in the tumor microenvironment: microbiome in cancer
  publication-title: Protein Cell
– volume: 3
  start-page: 13
  issue: 1
  year: 2023
  end-page: 32
  article-title: DNA damage and the gut microbiome: from mechanisms to disease outcomes
  publication-title: DNA
– volume: 12
  year: 2021
  article-title: Gut‐lung crosstalk in sepsis‐induced acute lung injury
  publication-title: Front Microbiol
– volume: 45
  start-page: 931
  issue: 4
  year: 2016
  end-page: 943
  article-title: Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide‐induced therapeutic immunomodulatory effects
  publication-title: Immunity
– volume: 27
  start-page: 5838
  issue: 18
  year: 2022
  article-title: A comprehensive analysis of microflora and metabolites in the development of ulcerative colitis into colorectal cancer based on the lung‐gut correlation theory
  publication-title: Molecules
– volume: 67
  start-page: 1168
  issue: 6
  year: 2018
  end-page: 1180
  article-title: Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine
  publication-title: Gut
– volume: 500
  start-page: 415
  issue: 7463
  year: 2013
  end-page: 421
  article-title: Signatures of mutational processes in human cancer
  publication-title: Nature
– volume: 115
  year: 2023
  article-title: Antitumor effect of invasive Lactobacillus plantarum delivering associated antigen gene sHSP between Trichinella spiralis and Lewis lung cancer cells
  publication-title: Int Immunopharmacol
– start-page: 483
  year: 1990
  end-page: 500
– volume: 29
  start-page: 1437
  issue: 6
  year: 2018
  end-page: 1444
  article-title: Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non‐small‐cell lung cancer
  publication-title: Ann Oncol
– volume: 15
  start-page: 2381
  issue: 11
  year: 2019
  end-page: 2392
  article-title: Dysbiosis of the gut microbiome is associated with tumor biomarkers in lung cancer
  publication-title: Int J Biol Sci
– volume: 25
  start-page: 1058
  issue: 6
  year: 2020
  end-page: 1109
  article-title: Epigenetic alterations in cancer
  publication-title: Front Biosci (Landmark Ed)
– volume: 130
  start-page: 1330
  issue: 8
  year: 2024
  end-page: 1348
  article-title: Lung cancer statistics, 2023
  publication-title: Cancer
– volume: 21
  start-page: 41
  issue: 1
  year: 2020
  article-title: Interaction between the microbiome and TP53 in human lung cancer (vol 19, 123, 2018)
  publication-title: Genome Biol
– volume: 6
  issue: 3
  year: 2011
  article-title: Previous lung diseases and lung cancer risk: a systematic review and meta‐analysis
  publication-title: PLoS One
– volume: 2
  issue: 26
  year: 2010
  article-title: Airway PI3K pathway activation is an early and reversible event in lung cancer development
  publication-title: Sci Transl Med
– volume: 11
  year: 2021
  article-title: The role of gut microbiota in lung cancer: from carcinogenesis to immunotherapy
  publication-title: Front Oncol
– volume: 108
  start-page: 4659
  year: 2011
  end-page: 4665
  article-title: The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host‐microbial interactions
  publication-title: Proc Nat Acad Sci USA
– volume: 24
  start-page: 3528
  issue: 13
  year: 2018
  end-page: 3538
  article-title: Modulation of pulmonary microbiota by antibiotic or probiotic aerosol therapy: a strategy to promote immunosurveillance against lung metastases
  publication-title: Cell Rep
– volume: 124
  start-page: 667
  issue: 4
  year: 2018
  end-page: 678
  article-title: Surgery versus stereotactic body radiation therapy for stage I non‐small cell lung cancer: a comprehensive review
  publication-title: Cancer
– volume: 9
  start-page: 1169
  issue: 12
  year: 2011
  end-page: 1178
  article-title: Lung injury induced by sepsis: lessons learned from large animal models and future directions for treatment
  publication-title: Expert Rev Anti Infect Ther
– volume: 26
  issue: 2
  year: 2023
  article-title: Streptococcus pneumoniae promotes lung cancer development and progression
  publication-title: iScience
– volume: 156
  start-page: 84
  issue: 1‐2
  year: 2014
  end-page: 96
  article-title: Microbiota‐generated metabolites promote metabolic benefits via gut‐brain neural circuits
  publication-title: Cell
– volume: 168
  start-page: 196
  year: 2021
  end-page: 216
  article-title: Delivery of genome‐editing biomacromolecules for treatment of lung genetic disorders
  publication-title: Adv Drug Deliv Rev
– volume: 9
  start-page: 704
  issue: 1
  year: 2018
  article-title: Publisher Correction: maturation of the gut microbiome and risk of asthma in childhood
  publication-title: Nat Commun
– volume: 73
  start-page: 751
  issue: 5
  year: 2024
  end-page: 769
  article-title: Faecal microbial transfer and complex carbohydrates mediate protection against COPD
  publication-title: Gut
– volume: 9
  start-page: 1757
  year: 2018
  article-title: PARP1 is up‐regulated in non‐small cell lung cancer tissues in the presence of the cyanobacterial toxin microcystin
  publication-title: Front Microbiol
– volume: 621
  year: 2022
  article-title: “Nanodecoys”—Future of drug delivery by encapsulating nanoparticles in natural cell membranes
  publication-title: Int J Pharm
– volume: 184
  start-page: 957
  issue: 8
  year: 2011
  end-page: 963
  article-title: Topographical continuity of bacterial populations in the healthy human respiratory tract
  publication-title: Am J Respir Crit Care Med
– volume: 1
  issue: 5
  year: 2016
  article-title: Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype
  publication-title: Nat Microbiol
– volume: 18
  start-page: 2
  issue: 1
  year: 2023
  article-title: Lactobacillus rhamnosus GG ameliorates radiation‐induced lung fibrosis via lncRNASNHG17/PTBP1/NICD axis modulation
  publication-title: Biol Direct
– volume: 261
  year: 2020
  article-title: Baicalein ameliorates ionizing radiation‐induced injuries by rebalancing gut microbiota and inhibiting apoptosis
  publication-title: Life Sci
– volume: 9
  start-page: 19
  issue: 1
  year: 2024
  article-title: Lung microbiome: new insights into the pathogenesis of respiratory diseases
  publication-title: Signal Transduct Target Ther
– volume: 63
  start-page: 2075
  issue: 5
  year: 1987
  end-page: 2083
  article-title: Indirect assessment of mucosal surface temperatures in the airways: theory and tests
  publication-title: J Appl Physiol (1985)
– volume: 16
  start-page: 3529
  issue: 28
  year: 2010
  end-page: 3540
  article-title: Probiotic Bio‐Three induces Th1 and anti‐inflammatory effects in PBMC and dendritic cells
  publication-title: World J Gastroenterol
– volume: 21
  start-page: 807
  issue: 1
  year: 2003
  end-page: 839
  article-title: Does the immune system see tumors as foreign or self?
  publication-title: Annu Rev Immunol
– volume: 276
  year: 2021
  article-title: Rutin loaded liquid crystalline nanoparticles inhibit non‐small cell lung cancer proliferation and migration in vitro
  publication-title: Life Sci
– volume: 13
  start-page: 2124
  issue: 9
  year: 2021
  article-title: Oral–gut microbiome axis in gastrointestinal disease and cancer
  publication-title: Cancers
– volume: 15
  start-page: 55
  issue: 1
  year: 2017
  end-page: 63
  article-title: Emerging pathogenic links between microbiota and the gut‐lung axis
  publication-title: Nat Rev Microbiol
– volume: 1862
  start-page: 858
  issue: 8
  year: 2019
  end-page: 869
  article-title: PTBP1 enhances exon11a skipping in Mena pre‐mRNA to promote migration and invasion in lung carcinoma cells
  publication-title: Biochim Biophys Acta Gene Regul Mech
– volume: 31
  start-page: 255
  issue: 3
  year: 2007
  end-page: 271
  article-title: Costimulatory receptors in jawed vertebrates: conserved CD28, odd CTLA4 and multiple BTLAs
  publication-title: Dev Comp Immunol
– volume: 77
  start-page: 1783
  issue: 8
  year: 2017
  end-page: 1812
  article-title: The host microbiome regulates and maintains human health: a primer and perspective for non‐microbiologists
  publication-title: Cancer Res
– volume: 20
  start-page: 642
  issue: 6
  year: 2014
  end-page: 647
  article-title: Lung microbiota promotes tolerance to allergens in neonates via PD‐L1
  publication-title: Nat Med
– volume: 10
  issue: 1
  year: 2024
  article-title: Unraveling the gut‐Lung axis: exploring complex mechanisms in disease interplay
  publication-title: Heliyon
– volume: 6
  start-page: 1050
  year: 2015
  article-title: Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches
  publication-title: Front Microbiol
– volume: 77
  start-page: 4696
  issue: 11
  year: 2009
  end-page: 4703
  article-title: Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae
  publication-title: Infect Immun
– volume: 300
  start-page: 63
  issue: 1
  year: 2010
  end-page: 73
  article-title: Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease
  publication-title: Int J Med Microbiol
– volume: 42
  start-page: 220
  issue: 1
  year: 2013
  end-page: 229
  article-title: Bronchial colonisation in patients with lung cancer: a prospective study
  publication-title: Eur Respir J
– volume: 70
  start-page: 8
  year: 2019
  end-page: 18
  article-title: Immunotherapeutic potential of Plasmodium against cancer by inducing immunomodulation
  publication-title: IJAR
– volume: 1878
  issue: 1
  year: 2023
  article-title: Intratumoral bacteria are an important “accomplice” in tumor development and metastasis
  publication-title: Biochim Biophys Acta Rev Cancer
– volume: 10
  start-page: 3171
  issue: 10
  year: 2018
  end-page: 3185
  article-title: Alterations of fecal bacterial communities in patients with lung cancer
  publication-title: Am J Transl Res
– volume: 17
  start-page: 225
  year: 2019
  article-title: Smoking and microbiome in oral, airway, gut and some systemic diseases
  publication-title: J Transl Med
– volume: 11
  start-page: 789
  issue: 4
  year: 2020
  end-page: 806
  article-title: Gut commensal derived‐valeric acid protects against radiation injuries
  publication-title: Gut Microbes
– volume: 22
  start-page: 40
  issue: 1
  year: 2023
  article-title: Lung cancer immunotherapy: progress, pitfalls, and promises
  publication-title: Mol Cancer
– volume: 4
  start-page: 988
  issue: 12
  year: 2005
  end-page: 1004
  article-title: Exploiting the PI3K/AKT pathway for cancer drug discovery
  publication-title: Nat Rev Drug Discov
– volume: 5
  start-page: 10
  issue: 1
  year: 2017
  article-title: Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open‐label study
  publication-title: Microbiome
– volume: 109
  start-page: 314
  year: 2016
  end-page: 341
  article-title: PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives
  publication-title: Eur J Med Chem
– volume: 8
  start-page: 1732
  year: 2017
  article-title: Prophylactic supplementation of Bifidobacterium longum 5(1A) protects mice from ovariectomy‐induced exacerbated allergic airway inflammation and airway hyperresponsiveness
  publication-title: Front Microbiol
– volume: 222
  start-page: 1818
  issue: Pt B
  year: 2022
  end-page: 1829
  article-title: Design of surface tailored carboxymethyl dextran‐protein based nanoconjugates for paclitaxel: spectroscopical characterizations and cytotoxicity assay
  publication-title: Int J Biol Macromol
– volume: 9
  start-page: 3477
  issue: 10
  year: 2020
  end-page: 3488
  article-title: Sodium butyrate‐activated TRAF6‐TXNIP pathway affects A549 cells proliferation and migration
  publication-title: Cancer Med
– volume: 14
  start-page: 154
  issue: 2
  year: 2023
  article-title: Potential links between the microbiota and T cell immunity determine the tumor cell fate
  publication-title: Cell Death Dis
– volume: 142
  start-page: 769
  issue: 4
  year: 2018
  end-page: 778
  article-title: Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects
  publication-title: Int J Cancer
– volume: 1
  start-page: 241
  issue: 3
  year: 2001
  end-page: 247
  article-title: History of vaccines and positioning of current trends
  publication-title: Curr Drug Targets Infect Disord
– volume: 2018
  year: 2018
  article-title: Glycyrrhizin suppresses the growth of human NSCLC cell line HCC827 by downregulating HMGB1 level
  publication-title: Biomed Res Int
– volume: 9
  start-page: 1168
  year: 2018
  article-title: Paradigms of lung microbiota functions in health and disease, particularly, in asthma
  publication-title: Front Physiol
– volume: 12
  start-page: 945
  issue: 4
  year: 2019
  end-page: 957
  article-title: Modulation of intestinal microbiota by glycyrrhizic acid prevents high‐fat diet‐enhanced pre‐metastatic niche formation and metastasis
  publication-title: Mucosal Immunol
– volume: 45
  issue: 1
  year: 2021
  article-title: Anti‐inflammatory and anticancer activities of Naringenin‐loaded liquid crystalline nanoparticles in vitro
  publication-title: J Food Biochem
– volume: 85
  year: 2020
  article-title: KRAS as a druggable target in NSCLC: rising like a phoenix after decades of development failures
  publication-title: Cancer Treat Rev
– volume: 66
  start-page: 625
  year: 2004
  end-page: 645
  article-title: Epithelial‐mesenchymal interactions in the developing lung
  publication-title: Annu Rev Physiol
– volume: 206
  start-page: 137
  issue: 4
  year: 2024
  article-title: Butyrate's (a short‐chain fatty acid) microbial synthesis, absorption, and preventive roles against colorectal and lung cancer
  publication-title: Arch Microbiol
– volume: 139
  start-page: 1906
  issue: 6
  year: 2017
  end-page: 1913
  article-title: Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow's milk allergy: 3‐year randomized controlled trial
  publication-title: J Allergy Clin Immunol
– volume: 313
  start-page: 848
  issue: 5788
  year: 2006
  end-page: 851
  article-title: Escherichia coli induces DNA double‐strand breaks in eukaryotic cells
  publication-title: Science
– volume: 82
  year: 2023
  article-title: Anticancer activity of NFκB decoy oligonucleotide‐loaded nanoparticles against human lung cancer
  publication-title: J Drug Deliv Sci Technol
– volume: 17
  start-page: 3
  issue: 1
  year: 2019
  end-page: 9
  article-title: Lung‐enriched mutations in the p53 tumor suppressor: a paradigm for tissue‐specific gain of oncogenic function
  publication-title: Mol Cancer Res
– volume: 6
  start-page: 68
  issue: 1
  year: 2018
  article-title: Reproducible protocols for metagenomic analysis of human faecal phageomes
  publication-title: Microbiome
– volume: 10
  issue: 5
  year: 2015
  article-title: Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study
  publication-title: PLoS One
– volume: 8
  issue: 6
  year: 2013
  article-title: Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents
  publication-title: PLoS One
– volume: 111
  start-page: 1589
  issue: 10
  year: 2003
  end-page: 1602
  article-title: Surfactant proteins A and D inhibit the growth of Gram‐negative bacteria by increasing membrane permeability
  publication-title: J Clin Invest
– volume: 141
  start-page: 1
  year: 2019
  end-page: 12
  article-title: The microbiome and cancer for clinicians
  publication-title: Crit Rev Oncol Hematol
– volume: 183
  start-page: 91
  year: 2018
  end-page: 101
  article-title: Biological activities and pharmaceutical applications of polysaccharide from natural resources: a review
  publication-title: Carbohydr Polym
– volume: 33
  start-page: 1
  year: 2015
  end-page: 7
  article-title: High‐throughput 16S rRNA gene sequencing reveals alterations of mouse intestinal microbiota after radiotherapy
  publication-title: Anaerobe
– volume: 569
  start-page: 641
  issue: 7758
  year: 2019
  end-page: 648
  article-title: The integrative human microbiome project
  publication-title: Nature
– ident: e_1_2_12_3_1
  doi: 10.4155/fmc-2019-0338
– ident: e_1_2_12_321_1
  doi: 10.1111/resp.12985
– ident: e_1_2_12_68_1
  doi: 10.1056/NEJMoa040938
– ident: e_1_2_12_209_1
  doi: 10.12703/P6-97
– ident: e_1_2_12_108_1
  doi: 10.1038/nri2316
– ident: e_1_2_12_31_1
  doi: 10.1038/s41571-023-00798-3
– ident: e_1_2_12_103_1
  doi: 10.1016/j.bbih.2023.100671
– ident: e_1_2_12_308_1
  doi: 10.1016/j.jtho.2019.04.007
– ident: e_1_2_12_169_1
  doi: 10.1186/s13059-016-1021-1
– ident: e_1_2_12_145_1
  doi: 10.3390/microorganisms8111741
– ident: e_1_2_12_265_1
  doi: 10.1002/cncr.31196
– ident: e_1_2_12_281_1
  doi: 10.1371/journal.pone.0126312
– year: 2023
  ident: e_1_2_12_136_1
  article-title: Propionate reinforces epithelial identity and reduces aggressiveness of non‐small cell lung carcinoma via chromatin remodelling
  publication-title: Biorxiv
– ident: e_1_2_12_207_1
  doi: 10.1016/j.cell.2016.01.049
– ident: e_1_2_12_25_1
  doi: 10.1146/annurev.immunol.21.120601.141135
– ident: e_1_2_12_354_1
  doi: 10.3389/fmicb.2022.999001
– ident: e_1_2_12_27_1
  doi: 10.1056/NEJMoa1916623
– ident: e_1_2_12_259_1
  doi: 10.3389/fcimb.2021.665159
– ident: e_1_2_12_36_1
  doi: 10.1016/S2213-2600(18)30510-1
– ident: e_1_2_12_70_1
  doi: 10.1002/ijc.22262
– ident: e_1_2_12_117_1
  doi: 10.3389/fcimb.2019.00090
– ident: e_1_2_12_227_1
  doi: 10.2174/1568005014606017
– ident: e_1_2_12_150_1
  doi: 10.1016/j.trsl.2012.02.005
– ident: e_1_2_12_109_1
  doi: 10.1152/ajpgi.00206.2004
– ident: e_1_2_12_110_1
  doi: 10.1016/S2666-5247(22)00203-8
– ident: e_1_2_12_168_1
  doi: 10.3389/fmed.2020.00554
– ident: e_1_2_12_125_1
  doi: 10.3389/fimmu.2019.00360
– ident: e_1_2_12_152_1
  doi: 10.1128/mBio.00037-15
– ident: e_1_2_12_323_1
  doi: 10.1016/j.jaci.2016.10.050
– ident: e_1_2_12_26_1
  doi: 10.1002/anie.201710398
– ident: e_1_2_12_341_1
  doi: 10.3322/caac.21820
– volume: 3
  start-page: 205
  issue: 4
  year: 2014
  ident: e_1_2_12_67_1
  article-title: Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations
  publication-title: Transl Lung Cancer Res
– ident: e_1_2_12_272_1
  doi: 10.1158/1078-0432.CCR-19-0960
– ident: e_1_2_12_51_1
  doi: 10.1016/j.lungcan.2016.10.016
– ident: e_1_2_12_66_1
  doi: 10.18632/oncotarget.186
– ident: e_1_2_12_19_1
  doi: 10.1016/j.jconrel.2021.08.010
– ident: e_1_2_12_300_1
  doi: 10.1016/j.ymben.2015.03.007
– ident: e_1_2_12_119_1
  doi: 10.1016/j.immuni.2018.04.022
– ident: e_1_2_12_307_1
  doi: 10.3389/fimmu.2018.00374
– ident: e_1_2_12_167_1
  doi: 10.1016/j.lungcan.2019.08.022
– ident: e_1_2_12_17_1
  doi: 10.1016/j.ijpharm.2022.121790
– ident: e_1_2_12_76_1
  doi: 10.1016/j.ijbiomac.2022.07.156
– ident: e_1_2_12_343_1
  doi: 10.1038/s41586-019-1238-8
– ident: e_1_2_12_328_1
  doi: 10.1016/j.rvsc.2021.03.006
– ident: e_1_2_12_212_1
  doi: 10.3389/fmicb.2018.01757
– ident: e_1_2_12_288_1
  doi: 10.3390/antiox11010065
– ident: e_1_2_12_166_1
  doi: 10.1038/s41392-023-01722-y
– ident: e_1_2_12_170_1
  doi: 10.1371/journal.pcbi.1002808
– ident: e_1_2_12_242_1
  doi: 10.1002/ijc.33557
– ident: e_1_2_12_219_1
  doi: 10.1186/s12931-019-1246-0
– ident: e_1_2_12_316_1
  doi: 10.1038/s41467-022-35580-z
– ident: e_1_2_12_2_1
– ident: e_1_2_12_130_1
  doi: 10.1038/s41579-020-0438-4
– ident: e_1_2_12_91_1
  doi: 10.1371/journal.pone.0066019
– ident: e_1_2_12_126_1
  doi: 10.1586/eri.11.141
– ident: e_1_2_12_151_1
  doi: 10.1164/rccm.201104-0655OC
– ident: e_1_2_12_284_1
  doi: 10.1136/gutjnl-2017-313789
– ident: e_1_2_12_38_1
  doi: 10.1158/0008-5472.CAN-16-2929
– ident: e_1_2_12_216_1
  doi: 10.1016/j.isci.2022.105923
– ident: e_1_2_12_326_1
  doi: 10.1111/resp.12990
– ident: e_1_2_12_298_1
  doi: 10.2217/imt-2018-0144
– ident: e_1_2_12_28_1
  doi: 10.1038/nature12477
– ident: e_1_2_12_210_1
  doi: 10.1038/nm.3568
– ident: e_1_2_12_13_1
  doi: 10.1111/jfbc.13572
– volume: 70
  start-page: 8
  year: 2019
  ident: e_1_2_12_338_1
  article-title: Immunotherapeutic potential of Plasmodium against cancer by inducing immunomodulation
  publication-title: IJAR
– ident: e_1_2_12_116_1
  doi: 10.1038/s41564-019-0574-7
– ident: e_1_2_12_199_1
  doi: 10.21037/tlcr-20-156
– ident: e_1_2_12_20_1
  doi: 10.1016/j.cbi.2023.110737
– ident: e_1_2_12_262_1
  doi: 10.1080/03602532.2020.1714645
– ident: e_1_2_12_303_1
  doi: 10.21037/apm-20-2183
– ident: e_1_2_12_6_1
  doi: 10.1177/20503121211034366
– ident: e_1_2_12_352_1
  doi: 10.1038/nm.2224
– ident: e_1_2_12_78_1
  doi: 10.1038/s43018-022-00351-8
– ident: e_1_2_12_285_1
  doi: 10.1111/jcmm.14289
– ident: e_1_2_12_203_1
  doi: 10.1126/scitranslmed.3000251
– ident: e_1_2_12_286_1
  doi: 10.3390/antiox11010065
– ident: e_1_2_12_16_1
  doi: 10.1007/s11356-022-19158-2
– ident: e_1_2_12_4_1
  doi: 10.1007/978-981-99-7141-1
– ident: e_1_2_12_293_1
  doi: 10.4046/trd.2018.0068
– ident: e_1_2_12_197_1
  doi: 10.1016/j.jtcvs.2020.01.104
– ident: e_1_2_12_260_1
  doi: 10.1089/rej.2022.0039
– ident: e_1_2_12_299_1
  doi: 10.1155/2020/2969287
– ident: e_1_2_12_47_1
  doi: 10.1128/IAI.00522-09
– ident: e_1_2_12_69_1
  doi: 10.1002/cncr.22315
– ident: e_1_2_12_175_1
  doi: 10.1002/em.21878
– ident: e_1_2_12_143_1
  doi: 10.1016/j.intimp.2020.107272
– ident: e_1_2_12_214_1
  doi: 10.1183/13993003.01406-2015
– ident: e_1_2_12_88_1
  doi: 10.1186/s40168-016-0225-7
– ident: e_1_2_12_44_1
  doi: 10.1016/S2214-109X(19)30488-7
– ident: e_1_2_12_181_1
  doi: 10.1002/ijc.24636
– ident: e_1_2_12_215_1
  doi: 10.21037/jtd-22-1825
– ident: e_1_2_12_221_1
  doi: 10.1016/j.ajpath.2017.01.003
– ident: e_1_2_12_63_1
  doi: 10.1146/annurev.physiol.66.032102.135749
– ident: e_1_2_12_266_1
  doi: 10.1016/j.jtcvs.2018.08.075
– ident: e_1_2_12_222_1
  doi: 10.1186/s13062-023-00357-x
– ident: e_1_2_12_54_1
  doi: 10.1146/annurev-immunol-051116-052133
– ident: e_1_2_12_263_1
  doi: 10.1155/2018/6916797
– ident: e_1_2_12_104_1
  doi: 10.1016/j.cell.2013.12.016
– ident: e_1_2_12_297_1
  doi: 10.1186/s40168-020-00811-2
– ident: e_1_2_12_336_1
  doi: 10.1111/1759-7714.15177
– ident: e_1_2_12_163_1
  doi: 10.1371/journal.ppat.1006798
– ident: e_1_2_12_226_1
  doi: 10.3389/fmicb.2023.1121863
– ident: e_1_2_12_271_1
  doi: 10.1002/pro6.1096
– ident: e_1_2_12_249_1
  doi: 10.3389/fmicb.2023.1165360
– volume: 54
  start-page: 3723
  issue: 14
  year: 1994
  ident: e_1_2_12_236_1
  article-title: Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea
  publication-title: Cancer Res
– ident: e_1_2_12_52_1
  doi: 10.1007/s13238-020-00813-8
– ident: e_1_2_12_244_1
  doi: 10.1016/j.biopha.2022.113528
– ident: e_1_2_12_30_1
  doi: 10.3389/fgene.2023.1120815
– ident: e_1_2_12_189_1
  doi: 10.3389/fmicb.2015.01050
– ident: e_1_2_12_115_1
  doi: 10.1053/j.gastro.2017.09.006
– ident: e_1_2_12_267_1
  doi: 10.1016/S0360-3016(00)01401-2
– ident: e_1_2_12_247_1
  doi: 10.3389/fcimb.2021.625913
– ident: e_1_2_12_33_1
  doi: 10.1016/j.bpg.2017.10.006
– ident: e_1_2_12_317_1
  doi: 10.1017/S0007114512005235
– ident: e_1_2_12_18_1
  doi: 10.1016/j.jddst.2023.104328
– ident: e_1_2_12_42_1
  doi: 10.1186/s12943-019-1008-0
– ident: e_1_2_12_278_1
  doi: 10.1186/s13014-020-01735-9
– ident: e_1_2_12_159_1
  doi: 10.1172/JCI16889
– volume: 5
  start-page: 423
  issue: 1
  year: 2015
  ident: e_1_2_12_196_1
  article-title: A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients
  publication-title: Am J Cancer Res
– ident: e_1_2_12_292_1
  doi: 10.1186/s40168-020-00845-6
– ident: e_1_2_12_327_1
  doi: 10.3389/fimmu.2020.00645
– ident: e_1_2_12_53_1
  doi: 10.1126/science.abc4552
– ident: e_1_2_12_148_1
  doi: 10.1172/JCI155101
– ident: e_1_2_12_261_1
  doi: 10.1016/j.carbpol.2020.115957
– ident: e_1_2_12_60_1
  doi: 10.2741/4847
– ident: e_1_2_12_58_1
  doi: 10.1111/jnc.12718
– ident: e_1_2_12_256_1
  doi: 10.1142/S0192415X22500951
– ident: e_1_2_12_155_1
  doi: 10.3389/fphys.2018.01168
– ident: e_1_2_12_350_1
  doi: 10.7812/TPP/19.129
– ident: e_1_2_12_154_1
  doi: 10.1371/journal.pone.0016384
– ident: e_1_2_12_122_1
  doi: 10.3389/fcimb.2020.00009
– ident: e_1_2_12_348_1
  doi: 10.1016/j.pt.2020.04.010
– ident: e_1_2_12_39_1
  doi: 10.1111/1469-0691.12023
– ident: e_1_2_12_65_1
  doi: 10.1172/JCI44871
– ident: e_1_2_12_337_1
  doi: 10.1038/cgt.2011.57
– ident: e_1_2_12_100_1
  doi: 10.1016/j.clim.2022.109013
– ident: e_1_2_12_156_1
  doi: 10.1038/s41590-019-0451-9
– ident: e_1_2_12_102_1
  doi: 10.1038/nrmicro2974
– ident: e_1_2_12_204_1
  doi: 10.1038/nmicrobiol.2016.31
– ident: e_1_2_12_233_1
  doi: 10.1016/j.immuni.2016.09.009
– ident: e_1_2_12_10_1
  doi: 10.3390/pharmaceutics13122008
– ident: e_1_2_12_200_1
  doi: 10.1126/science.1223813
– ident: e_1_2_12_287_1
  doi: 10.1080/19490976.2019.1709387
– ident: e_1_2_12_274_1
  doi: 10.3389/fgene.2020.566244
– ident: e_1_2_12_342_1
  doi: 10.1007/s00018-020-03452-8
– ident: e_1_2_12_121_1
  doi: 10.1016/j.semcancer.2021.07.005
– ident: e_1_2_12_194_1
  doi: 10.7554/eLife.04186
– ident: e_1_2_12_138_1
  doi: 10.1038/s41564-019-0498-2
– ident: e_1_2_12_161_1
  doi: 10.1038/nrmicro.2016.142
– ident: e_1_2_12_135_1
  doi: 10.3390/dna3010002
– ident: e_1_2_12_190_1
  doi: 10.1111/cmi.12308
– ident: e_1_2_12_324_1
  doi: 10.3389/fmicb.2017.01732
– ident: e_1_2_12_191_1
  doi: 10.7554/eLife.04186
– ident: e_1_2_12_61_1
  doi: 10.1245/s10434-020-08241-y
– ident: e_1_2_12_147_1
  doi: 10.1186/s13054-020-03320-8
– ident: e_1_2_12_77_1
  doi: 10.1038/nm.3854
– ident: e_1_2_12_114_1
  doi: 10.1038/s41467-018-03150-x
– ident: e_1_2_12_213_1
  doi: 10.1186/s13059-020-01961-0
– ident: e_1_2_12_162_1
  doi: 10.1016/S0140-6736(14)61136-3
– ident: e_1_2_12_282_1
  doi: 10.1016/j.anaerobe.2015.01.004
– ident: e_1_2_12_8_1
  doi: 10.1186/s12943-023-01740-y
– ident: e_1_2_12_82_1
  doi: 10.1177/0884533615609899
– volume: 21
  start-page: 658
  issue: 9
  year: 2018
  ident: e_1_2_12_211_1
  article-title: Helicobacter pylori infection and lung cancer: New insights and future challenges
  publication-title: Zhongguo Fei Ai Za Zhi
– ident: e_1_2_12_301_1
  doi: 10.1093/annonc/mdw321
– ident: e_1_2_12_202_1
  doi: 10.1164/rccm.201710-2118OC
– start-page: 1
  year: 2022
  ident: e_1_2_12_75_1
  article-title: Kinase inhibitors: an overview
  publication-title: Protein Kinase Inhibitors
– ident: e_1_2_12_113_1
  doi: 10.1016/j.critrevonc.2021.103404
– ident: e_1_2_12_80_1
  doi: 10.3390/cancers13092124
– ident: e_1_2_12_128_1
  doi: 10.1097/SHK.0000000000000565
– ident: e_1_2_12_302_1
  doi: 10.1111/1759-7714.13711
– ident: e_1_2_12_134_1
  doi: 10.1016/S1470-2045(12)70137-7
– ident: e_1_2_12_107_1
  doi: 10.1053/j.gastro.2013.04.056
– ident: e_1_2_12_224_1
  doi: 10.1038/s41419-018-1237-y
– ident: e_1_2_12_313_1
  doi: 10.1126/science.aac4255
– ident: e_1_2_12_158_1
  doi: 10.1152/jappl.1987.63.5.2075
– volume: 20
  start-page: 1569
  issue: 2
  year: 2019
  ident: e_1_2_12_248_1
  article-title: Propionate of a microbiota metabolite induces cell apoptosis and cell cycle arrest in lung cancer
  publication-title: Mol Med Rep
– ident: e_1_2_12_277_1
  doi: 10.1073/pnas.0504830102
– ident: e_1_2_12_56_1
  doi: 10.1016/j.oraloncology.2006.02.009
– ident: e_1_2_12_174_1
  doi: 10.1186/s12931-018-0959-9
– ident: e_1_2_12_255_1
  doi: 10.1016/j.ejphar.2021.174581
– ident: e_1_2_12_193_1
  doi: 10.1038/s41574-020-00427-4
– ident: e_1_2_12_322_1
  doi: 10.1016/j.clnu.2016.09.025
– volume: 20
  start-page: 4742
  issue: 22
  year: 2016
  ident: e_1_2_12_86_1
  article-title: The role of diet on gut microbiota composition
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 5
  start-page: 3111
  issue: 10
  year: 2015
  ident: e_1_2_12_179_1
  article-title: Discovery and validation of potential bacterial biomarkers for lung cancer
  publication-title: Am J Cancer Res
– ident: e_1_2_12_177_1
  doi: 10.1038/s41598-019-49195-w
– ident: e_1_2_12_41_1
  doi: 10.3389/fonc.2022.1063100
– ident: e_1_2_12_217_1
  doi: 10.1007/s12672-023-00748-6
– ident: e_1_2_12_129_1
  doi: 10.3389/fmicb.2021.779620
– ident: e_1_2_12_264_1
  doi: 10.1038/s41385-019-0144-6
– ident: e_1_2_12_173_1
  doi: 10.1186/s12967-019-1971-7
– volume: 6
  start-page: 205
  issue: 4
  year: 1946
  ident: e_1_2_12_229_1
  article-title: The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, MD, reviewed in the light of modern research
  publication-title: Cancer Res
– ident: e_1_2_12_188_1
  doi: 10.1371/journal.pone.0177062
– ident: e_1_2_12_57_1
  doi: 10.1016/j.lungcan.2018.07.013
– ident: e_1_2_12_276_1
  doi: 10.3390/nu13113866
– ident: e_1_2_12_220_1
  doi: 10.1186/s13059-018-1501-6
– ident: e_1_2_12_187_1
  doi: 10.1002/ijc.31098
– ident: e_1_2_12_294_1
  doi: 10.1007/s12032-023-01954-6
– ident: e_1_2_12_356_1
  doi: 10.3390/ijms25074051
– ident: e_1_2_12_183_1
  doi: 10.1016/j.critrevonc.2013.06.011
– ident: e_1_2_12_345_1
  doi: 10.1038/s42003-023-04592-w
– ident: e_1_2_12_146_1
  doi: 10.1158/0008-5472.CAN-18-4108
– ident: e_1_2_12_243_1
  doi: 10.1126/science.aan3706
– ident: e_1_2_12_208_1
  doi: 10.1016/j.celrep.2018.08.090
– ident: e_1_2_12_206_1
  doi: 10.1016/j.immuni.2017.04.005
– ident: e_1_2_12_72_1
  doi: 10.1159/000446447
– ident: e_1_2_12_250_1
  doi: 10.3390/cancers13010013
– ident: e_1_2_12_279_1
  doi: 10.3389/fphar.2021.643283
– ident: e_1_2_12_93_1
  doi: 10.1007/s00018-018-2943-4
– ident: e_1_2_12_344_1
  doi: 10.1038/nm.4517
– ident: e_1_2_12_153_1
  doi: 10.1164/rccm.201210-1913OC
– ident: e_1_2_12_340_1
  doi: 10.3892/mmr.2023.13082
– ident: e_1_2_12_64_1
  doi: 10.1007/s00432-010-0934-4
– ident: e_1_2_12_331_1
  doi: 10.1016/j.crvi.2018.03.004
– ident: e_1_2_12_140_1
  doi: 10.1093/jnci/djv199
– ident: e_1_2_12_137_1
  doi: 10.1007/s00203-024-03834-7
– volume: 10
  start-page: 3171
  issue: 10
  year: 2018
  ident: e_1_2_12_141_1
  article-title: Alterations of fecal bacterial communities in patients with lung cancer
  publication-title: Am J Transl Res
– ident: e_1_2_12_160_1
  doi: 10.1183/09031936.01.00228801
– ident: e_1_2_12_312_1
  doi: 10.3389/fimmu.2024.1343450
– ident: e_1_2_12_318_1
  doi: 10.1159/000342079
– ident: e_1_2_12_45_1
  doi: 10.1126/science.aay9189
– ident: e_1_2_12_253_1
  doi: 10.1016/j.jep.2023.116629
– ident: e_1_2_12_357_1
  doi: 10.1038/s41419-023-05560-2
– ident: e_1_2_12_40_1
  doi: 10.1016/j.cell.2012.04.037
– ident: e_1_2_12_127_1
  doi: 10.1016/j.biopha.2019.109363
– ident: e_1_2_12_320_1
  doi: 10.3389/fonc.2021.720842
– ident: e_1_2_12_171_1
  doi: 10.1158/1055-9965.EPI-10-1166
– volume: 9
  start-page: 2047
  issue: 9
  year: 2019
  ident: e_1_2_12_176_1
  article-title: The characterization of lung microbiome in lung cancer patients with different clinicopathology
  publication-title: Am J Cancer Res
– ident: e_1_2_12_94_1
  doi: 10.1007/s00394-017-1445-8
– ident: e_1_2_12_49_1
  doi: 10.1902/jop.2016.150597
– ident: e_1_2_12_270_1
  doi: 10.1016/j.adro.2020.10.018
– ident: e_1_2_12_275_1
  doi: 10.3389/fmicb.2018.01835
– ident: e_1_2_12_305_1
  doi: 10.1016/j.dci.2006.06.003
– ident: e_1_2_12_164_1
  doi: 10.1164/rccm.201210-1937OC
– ident: e_1_2_12_306_1
  doi: 10.3389/fimmu.2023.1171649
– ident: e_1_2_12_59_1
  doi: 10.1038/nrc.2016.66
– ident: e_1_2_12_251_1
  doi: 10.1016/j.carbpol.2017.12.009
– ident: e_1_2_12_252_1
  doi: 10.1016/j.crfs.2022.08.010
– ident: e_1_2_12_239_1
  doi: 10.2174/138920112800784835
– ident: e_1_2_12_99_1
  doi: 10.1038/ncomms7734
– ident: e_1_2_12_34_1
  doi: 10.1136/gutjnl-2017-315537
– ident: e_1_2_12_144_1
  doi: 10.1126/scitranslmed.aau9959
– ident: e_1_2_12_22_1
  doi: 10.3390/molecules28083475
– ident: e_1_2_12_309_1
  doi: 10.1111/1759-7714.13442
– ident: e_1_2_12_133_1
  doi: 10.1038/s41591-022-01779-2
– ident: e_1_2_12_142_1
  doi: 10.3389/fimmu.2020.00357
– ident: e_1_2_12_296_1
  doi: 10.4238/2015.May.25.16
– ident: e_1_2_12_118_1
  doi: 10.1186/s12887-019-1782-2
– ident: e_1_2_12_205_1
  doi: 10.1189/jlb.3MR0316-106R
– ident: e_1_2_12_85_1
  doi: 10.1016/j.cell.2014.09.053
– ident: e_1_2_12_232_1
  doi: 10.1126/science.1240527
– ident: e_1_2_12_315_1
  doi: 10.3389/fimmu.2021.772532
– ident: e_1_2_12_105_1
  doi: 10.1016/S0140-6736(03)12489-0
– ident: e_1_2_12_132_1
  doi: 10.3390/cancers14215405
– ident: e_1_2_12_358_1
  doi: 10.1038/s41392-023-01406-7
– ident: e_1_2_12_269_1
  doi: 10.14316/pmp.2020.31.3.124
– ident: e_1_2_12_11_1
  doi: 10.1016/j.jddst.2023.104579
– ident: e_1_2_12_178_1
  doi: 10.1183/09031936.00062212
– ident: e_1_2_12_218_1
  doi: 10.3389/fonc.2020.576855
– ident: e_1_2_12_304_1
  doi: 10.1038/nrc3239
– ident: e_1_2_12_234_1
  doi: 10.1007/s10517-011-1457-y
– ident: e_1_2_12_106_1
  doi: 10.1186/s12865-016-0187-3
– ident: e_1_2_12_223_1
  doi: 10.1016/j.bbagrm.2019.04.006
– ident: e_1_2_12_12_1
  doi: 10.1016/j.ijbiomac.2022.09.271
– ident: e_1_2_12_182_1
  doi: 10.1111/crj.12094
– ident: e_1_2_12_192_1
  doi: 10.1016/j.cmet.2012.10.007
– ident: e_1_2_12_349_1
  doi: 10.1016/j.trecan.2020.12.010
– ident: e_1_2_12_237_1
  doi: 10.1016/j.chembiol.2015.08.005
– ident: e_1_2_12_83_1
  doi: 10.1038/s41392-022-00974-4
– ident: e_1_2_12_84_1
  doi: 10.1097/00005176-199901000-00007
– ident: e_1_2_12_101_1
  doi: 10.1136/gutjnl-2023-330521
– ident: e_1_2_12_241_1
  doi: 10.1186/s13568-022-01428-4
– ident: e_1_2_12_96_1
  doi: 10.1111/j.1365-2672.2007.03322.x
– ident: e_1_2_12_87_1
  doi: 10.1155/2014/462740
– ident: e_1_2_12_201_1
  doi: 10.7150/ijbs.35980
– ident: e_1_2_12_112_1
  doi: 10.1183/16000617.0299-2020
– ident: e_1_2_12_334_1
  doi: 10.3748/wjg.v16.i28.3529
– ident: e_1_2_12_73_1
  doi: 10.1038/sj.onc.1207515
– ident: e_1_2_12_198_1
  doi: 10.1158/1055-9965.EPI-07-2817
– ident: e_1_2_12_225_1
  doi: 10.1016/j.cbi.2022.110282
– ident: e_1_2_12_238_1
  doi: 10.1046/j.1365-2567.2002.01498.x
– ident: e_1_2_12_90_1
  doi: 10.1101/gr.122705.111
– ident: e_1_2_12_5_1
  doi: 10.1016/B978-0-12-820658-4.00023-6
– ident: e_1_2_12_48_1
  doi: 10.1002/anie.200901917
– ident: e_1_2_12_157_1
  doi: 10.1038/mi.2016.108
– ident: e_1_2_12_314_1
  doi: 10.1002/cam4.5312
– ident: e_1_2_12_24_1
  doi: 10.1038/nrc.2016.36
– ident: e_1_2_12_43_1
  doi: 10.1016/j.bbcan.2022.188846
– ident: e_1_2_12_172_1
  doi: 10.1002/cncr.35128
– ident: e_1_2_12_319_1
  doi: 10.1016/j.ijmm.2009.08.006
– ident: e_1_2_12_55_1
  doi: 10.1016/j.ctrv.2020.101978
– ident: e_1_2_12_347_1
  doi: 10.1002/jobm.202000575
– ident: e_1_2_12_46_1
  doi: 10.1126/science.1127059
– ident: e_1_2_12_74_1
  doi: 10.1016/j.ejmech.2016.01.012
– ident: e_1_2_12_184_1
  doi: 10.1371/journal.pone.0017479
– ident: e_1_2_12_92_1
  doi: 10.1016/j.fshw.2017.07.003
– ident: e_1_2_12_290_1
  doi: 10.1007/978-981-15-2385-4_5
– ident: e_1_2_12_283_1
  doi: 10.1177/1099800420942830
– ident: e_1_2_12_268_1
  doi: 10.21037/jtd-20-2137
– volume-title: Lung Cancer
  ident: e_1_2_12_32_1
– ident: e_1_2_12_95_1
  doi: 10.1038/s41392-021-00687-0
– ident: e_1_2_12_98_1
  doi: 10.1016/j.celrep.2016.05.047
– ident: e_1_2_12_62_1
  doi: 10.1158/1541-7786.MCR-18-0357
– ident: e_1_2_12_111_1
  doi: 10.3390/nu11102403
– ident: e_1_2_12_245_1
  doi: 10.1002/cam4.2564
– ident: e_1_2_12_330_1
  doi: 10.1016/j.freeradbiomed.2016.11.013
– ident: e_1_2_12_131_1
  doi: 10.3390/molecules27185838
– ident: e_1_2_12_325_1
  doi: 10.3748/wjg.v23.i12.2149
– ident: e_1_2_12_333_1
  doi: 10.1073/pnas.0500098102
– ident: e_1_2_12_280_1
  doi: 10.3889/oamjms.2017.122
– volume: 51
  start-page: 4187
  issue: 16
  year: 1991
  ident: e_1_2_12_235_1
  article-title: Intracellular roles of SN‐38, a metabolite of the camptothecin derivative CPT‐11, in the antitumor effect of CPT‐11
  publication-title: Cancer Res
– ident: e_1_2_12_335_1
  doi: 10.1158/2326-6066.CIR-20-0051
– ident: e_1_2_12_257_1
  doi: 10.1016/j.ijbiomac.2022.05.185
– ident: e_1_2_12_79_1
  doi: 10.1016/j.addr.2020.05.002
– ident: e_1_2_12_310_1
  doi: 10.1093/annonc/mdy103
– ident: e_1_2_12_351_1
  doi: 10.1080/21507740.2021.1958096
– ident: e_1_2_12_240_1
  doi: 10.1136/gutjnl-2020-321031
– ident: e_1_2_12_258_1
  doi: 10.1016/S1875-5364(19)30003-2
– ident: e_1_2_12_89_1
  doi: 10.1038/nature09199
– ident: e_1_2_12_180_1
  doi: 10.1183/16000617.00002315
– ident: e_1_2_12_195_1
  doi: 10.1016/j.cllc.2023.06.011
– ident: e_1_2_12_329_1
  doi: 10.4049/jimmunol.176.4.2161
– ident: e_1_2_12_355_1
  doi: 10.1016/j.heliyon.2024.e24032
– ident: e_1_2_12_254_1
  doi: 10.1016/j.lfs.2020.118463
– ident: e_1_2_12_353_1
  doi: 10.1002/ame2.12022
– ident: e_1_2_12_120_1
  doi: 10.4049/jimmunol.178.4.2000
– ident: e_1_2_12_35_1
  doi: 10.1038/s41385-019-0160-6
– ident: e_1_2_12_346_1
  doi: 10.1186/s40168-018-0446-z
– ident: e_1_2_12_14_1
  doi: 10.1016/j.biopha.2022.112951
– ident: e_1_2_12_273_1
  doi: 10.1038/s41419-018-0304-8
– ident: e_1_2_12_165_1
  doi: 10.1016/j.critrevonc.2019.06.004
– ident: e_1_2_12_186_1
  doi: 10.1186/1749-8090-6-137
– ident: e_1_2_12_332_1
  doi: 10.1038/ni1112
– ident: e_1_2_12_15_1
  doi: 10.1016/j.lfs.2021.119436
– ident: e_1_2_12_246_1
  doi: 10.1002/mnfr.202100096
– ident: e_1_2_12_37_1
  doi: 10.1093/nutrit/nux062
– ident: e_1_2_12_71_1
  doi: 10.1038/nrd1902
– ident: e_1_2_12_231_1
  doi: 10.3390/ijms241411855
– ident: e_1_2_12_289_1
  doi: 10.1186/s10020-024-00873-0
– ident: e_1_2_12_295_1
  doi: 10.1200/JCO.2009.27.6204
– ident: e_1_2_12_339_1
  doi: 10.1016/j.intimp.2023.109708
– ident: e_1_2_12_9_1
  doi: 10.1038/s41591-021-01450-2
– ident: e_1_2_12_81_1
  doi: 10.1371/journal.ppat.1004923
– ident: e_1_2_12_311_1
  doi: 10.1002/cam4.4994
– ident: e_1_2_12_123_1
  doi: 10.1155/2017/5035371
– ident: e_1_2_12_139_1
  doi: 10.1164/rccm.201508-1545CI
– ident: e_1_2_12_230_1
  doi: 10.1007/978-1-4684-5766-7_52
– ident: e_1_2_12_124_1
  doi: 10.1016/j.trecan.2019.12.007
– volume: 26
  start-page: 154
  year: 2006
  ident: e_1_2_12_228_1
  article-title: The toxins of William B. Coley and the treatment of bone and soft‐tissue sarcomas
  publication-title: Iowa Orthop J
– ident: e_1_2_12_185_1
  doi: 10.1099/jmm.0.04845-0
– ident: e_1_2_12_149_1
  doi: 10.1038/s42255-023-00898-5
– ident: e_1_2_12_21_1
  doi: 10.1016/j.nano.2020.102303
– ident: e_1_2_12_7_1
  doi: 10.3389/fonc.2021.750657
– ident: e_1_2_12_97_1
  doi: 10.1073/pnas.1006451107
– ident: e_1_2_12_23_1
  doi: 10.1002/cpt.810
– ident: e_1_2_12_29_1
  doi: 10.1186/s12935-023-02990-y
– ident: e_1_2_12_291_1
  doi: 10.3389/fmicb.2020.00301
– ident: e_1_2_12_50_1
  doi: 10.3389/fonc.2018.00520
SSID ssj0002511790
Score 2.370197
SecondaryResourceType review_article
Snippet Lung cancer (LC) continues to pose the highest mortality and exhibits a common prevalence among all types of cancer. The genetic interaction between human...
Abstract Lung cancer (LC) continues to pose the highest mortality and exhibits a common prevalence among all types of cancer. The genetic interaction between...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e70018
SubjectTerms Chemotherapy
dysbiosis
gut microbiome
Immunotherapy
Lung cancer
Lung diseases
lung microbiome
probiotics
Radiation therapy
Review
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwEB6hqkJcEOU3tCAjuIAUmk2yjqc3qKjg0MIBpN4s_9KV2qTa7FbiIXgHnoUn69jORruiggtXexRNZsbjz_L4G4BXghsjsHG5UL6gA4qd5pQDMW-88Zprbnmdmk00Jyfi9BS_rLX6CjVhiR44GW6fW1P7qTO1QawDs0zt0VdWW6sIiaMN2ZdQz9phKuTgAJwbLEY-0nL_wnTl23DJKjZ2oEjUfxO6_LNIch28xt3n6B7cHWAje5fU3YFbrr0Pt4-Hi_EH8PPTqtkI6zz7vlww1Vp2TiuZ2R-9nnX9rGddm0ZM8PScxdKsRMsRpeOdAbvo7NDRi6k-yFAg0PbG1h5qsVQ-3h8w9ftXqEmfu7NUB8_SS5iH8O3ow9fDj_nQaSE3hGdEbn2FGq3A2nNfGPQohHaC86bUhfK-IpRi9BSNtyVlam2x8Ep4ZQhcikb56hFstV3rngDjghDiVBGQcZPaiYmyhCBVILkqdWW4yuD1yvrSDDTkoRvGuUwEyqUMnpLRUxm8HGUvE_nGjVLvgxNHiUCYHQcojOQQRvJfYZTB3ioE5LCKe1lN6oa051hl8GKcJrOHSxXVum4ZZKrAwkaCGTxOETNqUiHBO0qRGYiNWNpQdXOmnZ1Fjm8C6oIXSB99E8PuL_8vjw8_x_IB8fR_WGIX7pQE3FLJzh5sLeZL9wy2zdVi1s-fx2V2DV3oMqA
  priority: 102
  providerName: Directory of Open Access Journals
Title Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmco2.70018
https://www.ncbi.nlm.nih.gov/pubmed/39584048
https://www.proquest.com/docview/3147231693
https://www.proquest.com/docview/3132612472
https://pubmed.ncbi.nlm.nih.gov/PMC11586092
https://doaj.org/article/6dc4f5ec4c99473284f9f3dbdda6059d
Volume 5
WOSCitedRecordID wos001369991100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2688-2663
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511790
  issn: 2688-2663
  databaseCode: DOA
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2688-2663
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511790
  issn: 2688-2663
  databaseCode: M~E
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2688-2663
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511790
  issn: 2688-2663
  databaseCode: 7X7
  dateStart: 20200601
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2688-2663
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511790
  issn: 2688-2663
  databaseCode: BENPR
  dateStart: 20200601
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content
  customDbUrl:
  eissn: 2688-2663
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511790
  issn: 2688-2663
  databaseCode: WIN
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 2688-2663
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511790
  issn: 2688-2663
  databaseCode: 24P
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtQwFL0qLUJseD8CZWQEG5DS5jWOjdjQqhVddBghELOL_GxHahOUzCDxEfwD38KXcW1n0o6okBAbL5KbyHGOr4_t63MBXjKqFOOliZmwCU5Q9DhGH8jj0iorqaSaFiHZRDmZsNmMTzfg7eosTNCHGBbcXM_w_tp1cCG73QvR0HPVZDtu15Rdg600zZlL3JAV02GFxZHn0i-yZNTBAcfWQZ802714fG1E8sL9V7HNP4MmL5NZPxod3v6_77gDt3oWSt4F2NyFDVPfgxvH_T77ffhxtMpdQhpLTpYLImpNztAxEP29k_Omm3ekqcMV5YDTEh_pFVQ-vLXfgiDnje4ThBHRORvEFY6W5NK5LxKi0bs3RPz66ULcW3MawupJOFjzAD4fHnzafx_3iRtihfSIxdrmXHLNeGGpTRS3nDFpGKVlJhNhbY6kR8kxV1Zn6Pil5okVzAqFXJWVwuYPYbNuavMYCGVIOMcC_51JC8NSoZGQCqeZlclcURHBq9XPq1Svau6Sa5xVQY85q1z7Vr59I3gx2H4NWh5XWu05DAwWTn_bX2jak6rvzhXVqrBjowrFeeH0jgrLba6l1gLnh1xHsL1CUNU7ha7K06LE2lOeR_B8uI3N7vZoRG2apbPJnagbGkbwKABuqEnOkS2ix42ArUFxrarrd-r5qZcMR97PaMLxpa89Fv_y_dXx_gcfjcCe_IvxU7iZId8LkT7bsLlol-YZXFffFvOuHfmeiWU5K33JRrC1dzCZfhz5RRAsvxxNfgPsakTt
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtQwFL2CgoAN70eggBFsQArNJBnHZgcVVUd0BhZFdGf52Y7UJiiZQeIj-Ae-hS_j2s6kHVEhIbbJTeTH8fWxfX0uwAtGtWa8simTLsMFihmn6AN5WjntFFXU0DImm6hmM3ZwwD_1sTn-LkzUhxg23PzICP7aD3C_Ib11qhp6opv8tT82ZRfhUolMw2du-DKZDVssnj1XYZclpx4POLkOAqX51unna1NSUO4_j27-GTV5ls2G6Wjnxn9W5CZc73koeRuBcwsu2Po2XJn2J-134Mdklb2ENI4cLhdE1oYco2sg5nun5k0370hTxyfaQ6clIdYr6nwE63AIQU4a06cII7LzNogsnC_JmZtfJMajd2-I_PXTB7m39igG1pN4teYufN55v7-9m_apG1KNBImlxhVcccN46ajLNHecMWUZpVWuMulcgbRHqzHXzuTo-pXhmZPMSY1slVXSFfdgo25q-wAIZUg5xxI7z45Ky0bSICWVXjUrV4WmMoGXq94Tutc19-k1jkVUZM6Fb18R2jeB54Pt16jmca7VOw-CwcIrcIcHTXso-gEtqNGlG1tdas5Lr3hUOu4Ko4yRuELkJoHNFYRE7xY6UYzKCktPeZHAs-E1Nrs_pZG1bZbepvCybmiYwP2IuKEkBUe-iD43AbaGxbWirr-p50dBNByZP6MZx5--CmD8S_3FdPtjiEdgD__F-Clc3d2f7om9yezDI7iWI_uLcT-bsLFol_YxXNbfFvOufRKG6W9ZwUPY
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtQwFL2Cgio2vB-BAkawASltJnEcmx0URlTQYRYgdRf52Y7UJtVkBomP4B_4Fr6MazuTdkSFhNjaN5FjH1-f2NfnArzgTGsuKpty6TL8QTFlij5QpJXTTjHFDKMx2UQ1mfCDAzHtY3P8XZioDzFsuPmZEfy1n-D21LidM9XQE93m2_7YlF-GK7SsRh7UOZ0OWyyePVdhlyVnHg-4uA4CpfnO2eNrS1JQ7r-Ibv4ZNXmezYblaHzjPz_kJlzveSh5E4FzCy7Z5jZs7vcn7Xfgx94qewlpHTlcLohsDDlG10DM907N2m7WkbaJJdpDZ05CrFfU-QjW4RCCnLSmTxFGZOdtEFm4XpJzN79IjEfvXhP566cPcp_boxhYT-LVmrvwdfz-y-6HtE_dkGokSDw1rhBKGC6oYy7TwgnOleWMVbnKpHMF0h6tSqGdydH1KyMyJ7mTGtkqr6Qr7sFG0zb2ARDGkXKWEgfPjqjlI2mQkkqvmpWrQjOZwMvV6NW61zX36TWO66jInNe-f-vQvwk8H2xPo5rHhVZvPQgGC6_AHQra-WHdT-iaGU1daTXVQlCveESdcIVRxkj8QxQmga0VhOreLXR1MaIVtp6JIoFnQzV2uz-lkY1tl96m8LJuaJjA_Yi4oSWFQL6IPjcBvobFtaau1zSzoyAajsyfs0zgS18FMP7l--v93c8hHoE__Bfjp7A5fTeuP-1NPj6CazmSvxj2swUbi_nSPoar-tti1s2fhFn6G-OKQu8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+gut+and+lung+dysbiosis+on+lung+cancer+progression+and+their+modulation+as+promising+therapeutic+targets%3A+a%C2%A0comprehensive+review&rft.jtitle=MedComm+%282020%29&rft.au=Thapa%2C+Rajan&rft.au=Magar%2C+Anjana+Thapa&rft.au=Shrestha%2C+Jesus&rft.au=Panth%2C+Nisha&rft.date=2024-12-01&rft.issn=2688-2663&rft.eissn=2688-2663&rft.volume=5&rft.issue=12&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Fmco2.70018&rft.externalDBID=10.1002%252Fmco2.70018&rft.externalDocID=MCO270018
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2688-2663&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2688-2663&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2688-2663&client=summon